VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Vaccine Mechanisms
VaximmutorDB
Vaxism
Vaxar
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UMMS Logo

Vaxlert: Peer-reviewed Vaccine Publications in Current Month

From May 01, 2022 To May 17, 2022:


Bacillus anthracis (Anthrax)

  1. Nikolaev S. Pharmacological evaluation of a complex drug against anthrax and parasitosis of Rangifer tarandus FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555238]

Brucella (Brucellosis)

  1. Al Bakr S, Alaithan MA. Immune complex-mediated glomerulonephritis post COVID-19 vaccination in a patient with concomitant Brucellosis Saudi medical journal 43(5):522-525 2022 [PMID: 35537721]
  2. He CY, Yang JH, Ye YB, Zhao HL, Liu MZ, Yang QL, Liu BS, He S, Chen ZL. Proteomic and Antibody Profiles Reveal Antigenic Composition and Signatures of Bacterial Ghost Vaccine of <i>Brucella abortus</i> A19 Frontiers in immunology 13:874871 2022 [PMID: 35529865]

Chlamydia psittaci (Psittacosis)

  1. Li Q, Chen S, Yan Z, Fang H, Wang Z, He C. A Novel Intranasal Vaccine With PmpGs + MOMP Induces Robust Protections Both in Respiratory Tract and Genital System Posting <i>Chlamydia psittaci</i> Infection Frontiers in veterinary science 9:855447 2022 [PMID: 35529835]

Clostridium perfringens

  1. Brysgel T, Kozub N, Bresnahan C, Austriaco N. Developing a COVID-19 Yeast Oral Vaccine for Low Income Countries FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555624]
  2. Yu C, Tong Y, Li Q, Wang T, Yang Z. <i>Trans</i>-anethole Ameliorates Intestinal Injury Through Activation of Nrf2 Signaling Pathway in Subclinical Necrotic Enteritis-Induced Broilers Frontiers in veterinary science 9:877066 2022 [PMID: 35518639]
  3. van Eerden E, Santos RR, Molist F, Dardi M, Pantoja-Millas LA, Molist-Badiola J, Baratelli M, Pages M. Efficacy of an attenuated vaccine against avian coccidiosis in combination with feed additives based on organic acids and essential oils on production performance and intestinal lesions in broilers experimentally challenged with necrotic enteritis Poultry science 101(6):101848 2022 [PMID: 35544960]

Coronavirus

  1. Casado JL, Vizcarra P, Haemmerle J, Velasco H, Martín-Hondarza A, Rodríguez-Domínguez MJ, Velasco T, Martín S, Romero-Hernández B, Fernández-Escribano M, Vallejo A. Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2 Vaccine: X 11:100165 2022 [PMID: 35529539]
  2. Vuong L, Bidwell JT, Apesoa-Varano EC, Cothran FA, Catz SL. COVID-19 vaccine hesitancy and intent in California registered nurses Vaccine: X 11:100162 2022 [PMID: 35492506]
  3. Chaurasia B, Chavda V, Lu B, Garg K, Montemurro N. Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination Brain, behavior, & immunity - health 22:100463 2022 [PMID: 35496775]
  4. Breuer J, Barth P, Noe Y, Shalamova L, Goesmann A, Weber F, Rossbach O. What goes around comes around: Artificial circular RNAs bypass cellular antiviral responses Molecular therapy. Nucleic acids 28:623-635 2022 [PMID: 35497503]
  5. Adibzadeh S, Amiri S, Nia GE, Taleghani MR, Bijarpas ZK, Maserat N, Maali A, Azad M, Behzad-Behbahani A. Therapeutic approaches and vaccination in fighting COVID-19 infections: A review Gene reports 27:101619 2022 [PMID: 35530725]
  6. Sartaj Sohrab S, Aly El-Kafrawy S, Ibraheem Azhar E. In silico prediction and experimental evaluation of potential siRNAs against SARS-CoV-2 inhibition in Vero E6 cells Journal of King Saud University. Science 34(4):102049 2022 [PMID: 35493709]
  7. Torres JL, Ozorowski G, Andreano E, Liu H, Copps J, Piccini G, Donnici L, Conti M, Planchais C, Planas D, Manganaro N, Pantano E, Paciello I, Pileri P, Bruel T, Montomoli E, Mouquet H, Schwartz O, Sala C, De Francesco R, Wilson IA, Rappuoli R, Ward AB. Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody Proceedings of the National Academy of Sciences of the United States of America 119(20):e2120976119 2022 [PMID: 35549549]
  8. Cole KA, Zhou AY, Jones T, Moore WJ, Chandler EL, Zafonte VB, Morrisette T, Gauthier TP, Kisgen J, Barner A, Johnson MD, Tagare RD, Justo JA. How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(Supplement_3):e23-e33 2022 [PMID: 35568481]
  9. Bari A, Heymann M, Cohen RJ, Zhao R, Szabo L, Apas Vasandani S, Khubchandani A, DiLorenzo M, Coffee M. Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74(Supplement_3):e4-e9 2022 [PMID: 35568473]
  10. Taeschler P, Adamo S, Deng Y, Cervia C, Zurbuchen Y, Chevrier S, Raeber ME, Hasler S, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Bodenmiller B, Boyman O, Nilsson J. T cell recovery and evidence of persistent immune activation 12 months after severe COVID-19 Allergy 2022 [PMID: 35567391]
  11. Efe C, Kulkarni AV, Beretta-Piccoli BT, Magro B, Stättermayer AF, Cengiz M, Clayton-Chubb D, Lammert C, Bernsmeier C, Gül Ö, la Tijera FH, Anders M, Lytvyak E, Akın M, Purnak T, Liberal R, Peralta M, Ebik B, Duman S, Demir N, Balaban Y, Urzua Á, Contreras F, Venturelli MG, Bilgiç Y, Medina A, Girala M, Günşar F, Londoño MC, Androutsakos T, Kisch A, Yurci A, Güzelbult F, Çağın YF, Avcı E, Akyıldız M, Dindar-Demiray EK, Harputluoğlu M, Kumar R, Satapathy SK, Mendizabal M, Silva M, Fagiuoli S, Roberts SK, Soylu NK, Idilman R, Yoshida EM, Montano-Loza AJ, Dalekos GN, Ridruejo E, Schiano TD, Wahlin S. Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome Hepatology (Baltimore, Md.) 2022 [PMID: 35567545]
  12. Toyama Y, Kamiya K, Maekawa T, Komine M, Ohtsuki M. Pyoderma gangrenosum following vaccination against coronavirus disease-2019: a case report International journal of dermatology 2022 [PMID: 35567368]
  13. Mohammed AH, Hassan BAR, Wayyes AM, Al-Tukmagi HF, Blebil A, Dujaili J, Nasr MH, El Hajj MS, Malaeb D, Alhija SA, Kateeb E, Amro A, Al-Taweel D, Al Juma MA, Al-Ani OA, Farhan SS, Darwish RM, Al-Zaabi AT. Exploring the quality of life of cosmetic users: A cross-sectional analysis from eight Arab countries in the Middle East Journal of cosmetic dermatology 2022 [PMID: 35567513]
  14. Brito-Dellan N, Tsoukalas N, Font C. Thrombosis, cancer, and COVID-19 Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2022 [PMID: 35567609]
  15. Madej M, Sebastian A, Morgiel E, Korman L, Szmyrka M, Sokolik R, Chodyra M, Walas-Antoszek M, Andrasiak I, Świerkot J. The assessment of the risk of COVID-19 infection and its course in the medical staff of a COVID-only and a non-COVID hospital Advances in clinical and experimental medicine : official organ Wroclaw Medical University 2022 [PMID: 35555868]
  16. Alagheband Bahrami A, Azargoonjahromi A, Sadraei S, Aarabi A, Payandeh Z, Rajabibazl M. An overview of current drugs and prophylactic vaccines for coronavirus disease 2019 (COVID-19) Cellular & molecular biology letters 27(1):38 2022 [PMID: 35562685]
  17. Nabi-Afjadi M, Heydari M, Zalpoor H, Arman I, Sadoughi A, Sahami P, Aghazadeh S. Lectins and lectibodies: potential promising antiviral agents Cellular & molecular biology letters 27(1):37 2022 [PMID: 35562647]
  18. Yokote S, Ueda H, Shimizu A, Okabe M, Yamamoto K, Tsuboi N, Yokoo T. IgA nephropathy with glomerular capillary IgA deposition following SARS-CoV-2 mRNA vaccination: a report of three cases CEN case reports 2022 [PMID: 35562631]
  19. Chiu NC, Lo KH, Chen CC, Huang SY, Weng SL, Wang CJ, Kuo HH, Chi H, Lien CH, Tai YL, Lin CY. The impact of COVID-19 on routine vaccinations in Taiwan and an unexpected surge of pneumococcal vaccination Human vaccines & immunotherapeutics :1-9 2022 [PMID: 35561305]
  20. Lv J, Wu H, Xu J, Liu J. Immunogenicity and safety of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine: a systematic review Infectious diseases of poverty 11(1):53 2022 [PMID: 35562753]
  21. Ezzemani W, Kettani A, Sappati S, Kondaka K, El Ossmani H, Tsukiyama-Kohara K, Altawalah H, Saile R, Kohara M, Benjelloun S, Ezzikouri S. Reverse vaccinology-based prediction of a multi-epitope SARS-CoV-2 vaccine and its tailoring to new coronavirus variants Journal of biomolecular structure & dynamics :1-22 2022 [PMID: 35549819]
  22. Pinpathomrat N, Intapiboon P, Seepathomnarong P, Ongarj J, Sophonmanee R, Hengprakop J, Surasombatpattana S, Uppanisakorn S, Mahasirimongkol S, Sawaengdee W, Phumiamorn S, Sapsutthipas S, Kongkamol C, Ingviya T, Sangsupawanich P, Chusri S. Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population NPJ vaccines 7(1):52 2022 [PMID: 35562372]
  23. Baker D, MacDougall A, Kang AS, Schmierer K, Giovannoni G, Dobson R. Seroconversion following COVID-19 vaccination: can we optimize protective response in CD20-treated individuals? Clinical and experimental immunology 207(3):263-271 2022 [PMID: 35553629]
  24. Teixeira LMC, Coimbra JTS, Ramos MJ, Fernandes PA. Transmembrane Protease Serine 2 Proteolytic Cleavage of the SARS-CoV-2 Spike Protein: A Mechanistic Quantum Mechanics/Molecular Mechanics Study to Inspire the Design of New Drugs To Fight the COVID-19 Pandemic Journal of chemical information and modeling 2022 [PMID: 35549216]
  25. Whitehouse CL, Harris C, Charlton P, Hare N. The changing paradigm of research delivery during a pandemic - a reflective account Nurse researcher 2022 [PMID: 35545928]
  26. Lim CP, Kok BH, Lim HT, Chuah C, Abdul Rahman B, Abdul Majeed AB, Wykes M, Leow CH, Leow CY. Recent trends in next generation immunoinformatics harnessed for universal coronavirus vaccine design Pathogens and global health :1-18 2022 [PMID: 35550001]
  27. Kaku CI, Bergeron AJ, Ahlm C, Normark J, Sakharkar M, Forsell MNE, Walker LM. Recall of pre-existing cross-reactive B cell memory following Omicron BA.1 breakthrough infection Science immunology :eabq3511 2022 [PMID: 35549299]
  28. Alghamdi HY, Alrashed AM, Jawhari AM, Abdel-Moneim AS. Neuropsychiatric symptoms in post COVID-19 long haulers Acta neuropsychiatrica :1-25 2022 [PMID: 35543105]
  29. Langerbeins P, Hallek M. COVID-19 in patients with hematologic malignancy Blood 2022 [PMID: 35544585]
  30. Yamada Y, Ishizuka S, Arai M, Maruyama M, Harashima H. Recent advances in delivering RNA-based therapeutics to mitochondria Expert opinion on biological therapy :1-11 2022 [PMID: 35543589]
  31. Lipp HP. [Vaccines against coronavirus disease 2019 (COVID-19) : Efficacy comparison, safety aspects, and current challenges] Der Internist 2022 [PMID: 35543726]
  32. Ko KKK, Yingtaweesittikul H, Tan TT, Wijaya L, Cao DY, Goh SS, Abdul Rahman NB, Chan KXL, Tay HM, Sim JHC, Chan KS, Oon LLE, Nagarajan N, Suphavilai C. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts Microbiology spectrum :e0079122 2022 [PMID: 35543562]
  33. Creech CB, Anderson E, Berthaud V, Yildirim I, Atz AM, Melendez Baez I, Finkelstein D, Pickrell P, Kirstein J, Yut C, Blair R, Clifford RA, Dunn M, Campbell JD, Montefiori DC, Tomassini JE, Zhao X, Deng W, Zhou H, Ramirez Schrempp D, Hautzinger K, Girard B, Slobod K, McPhee R, Pajon R, Das R, Miller JM, Schnyder Ghamloush S. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age The New England journal of medicine 2022 [PMID: 35544369]
  34. Lu S, Duplat D, Benitez-Bolivar P, León C, Villota SD, Veloz-Villavicencio E, Arévalo V, Jaenes K, Guo Y, Cicek S, Robinson L, Peidis P, Pearson JD, Woodgett J, Mazzulli T, Ponce P, Restrepo S, González JM, Bernal A, Guevara-Suarez M, Pardee K, Cevallos VE, González C, Bremner R. Multicenter international assessment of a SARS-CoV-2 RT-LAMP test for point of care clinical application PloS one 17(5):e0268340 2022 [PMID: 35544541]
  35. de Boer SE, Berger SP, van Leer-Buter CC, Kroesen BJ, van Baarle D, Sanders JF. Enhanced Humoral Immune Response After COVID-19 Vaccination in Elderly Kidney Transplant Recipients on Everolimus Versus Mycophenolate Mofetil-containing Immunosuppressive Regimens Transplantation 2022 [PMID: 35546527]
  36. Aboulatta L, Kowalec K, Delaney J, Alessi-Severini S, Leong C, Falk J, Eltonsy S. Trends of COVID-19 incidence in Manitoba and public health measures: March 2020 to February 2022 BMC research notes 15(1):162 2022 [PMID: 35538498]
  37. Malerbi FK, Schoeps VA, T F Matos K. Paracentral acute middle maculopathy in Susac syndrome after dual exposure to SARS-CoV-2 antigen BMJ case reports 15(5) 2022 [PMID: 35537770]
  38. Chong Z, Karl CE, Halfmann PJ, Kawaoka Y, Winkler ES, Keeler SP, Holtzman MJ, Yu J, Diamond MS. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron Cell reports 39(6):110799 2022 [PMID: 35523172]
  39. Huang YH, Yeh CT, Hsu CW, Lin YH. Reduction of ACE2 serum concentrations by telbivudine in chronic hepatitis B patients Current molecular medicine 2022 [PMID: 35538813]
  40. Mettelman RC, Allen EK, Thomas PG. Mucosal immune responses to infection and vaccination in the respiratory tract Immunity 55(5):749-780 2022 [PMID: 35545027]
  41. Sette A, Saphire EO. Inducing broad-based immunity against viruses with pandemic potential Immunity 55(5):738-748 2022 [PMID: 35545026]
  42. El Sahly HM, Baden LR, Essink B, Montefiori D, McDermont A, Rupp R, Lewis M, Swaminathan S, Griffin C, Fragoso V, Miller VE, Girard B, Paila YD, Deng W, Tomassini JE, Paris R, Schödel F, Das R, August A, Leav B, Miller JM, Zhou H, Pajon R. Humoral Immunogenicity of the mRNA-1273 Vaccine in the Phase 3 COVE Trial The Journal of infectious diseases 2022 [PMID: 35535503]
  43. Larkin HD. Four Vaccine Doses Prevented Severe Omicron COVID-19 Better Than 3 JAMA 327(18):1748 2022 [PMID: 35536278]
  44. Larkin HD. Two mRNA COVID-19 Vaccines Stimulate Different Immune Responses JAMA 327(18):1748 2022 [PMID: 35536277]
  45. Blumberg EA, Noll JH, Tebas P, Fraietta JA, Frank I, Marshall AE, Chew A, Veloso EA, Carulli A, Rogal W, Gaymon AL, Schmidt AH, Barnette T, Jurek R, Martins R, Hudson BM, Chavda K, Bailey CM, Church SE, Noorchashm H, Hwang WT, June CH, Hexner EO. Phase 1 trial of cyclosporine for hospitalized patients with COVID-19 JCI insight 2022 [PMID: 35536669]
  46. Sonnleitner ST, Prelog M, Sonnleitner S, Hinterbichler E, Halbfurter H, Kopecky DBC, Almanzar G, Koblmüller S, Sturmbauer C, Feist L, Horres R, Posch W, Walder G. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host Nature communications 13(1):2560 2022 [PMID: 35538074]
  47. Prasad S, Kalafat E, Blakeway H, Townsend R, O'Brien P, Morris E, Draycott T, Thangaratinam S, Le Doare K, Ladhani S, von Dadelszen P, Magee LA, Heath P, Khalil A. Systematic review and meta-analysis of the effectiveness and perinatal outcomes of COVID-19 vaccination in pregnancy Nature communications 13(1):2414 2022 [PMID: 35538060]
  48. Freund O, Tau L, Weiss TE, Zornitzki L, Frydman S, Jacob G, Bornstein G. Associations of vaccine status with characteristics and outcomes of hospitalized severe COVID-19 patients in the booster era PloS one 17(5):e0268050 2022 [PMID: 35536849]
  49. . COVID-19 vaccine hesitancy after side effects to the first vaccine: what are our options? QJM : monthly journal of the Association of Physicians 115(5):267 2022 [PMID: 35535603]
  50. Vimalajeewa D, Balasubramaniam S, Berry DP, Barry G. Virus particle propagation and infectivity along the respiratory tract and a case study for SARS-CoV-2 Scientific reports 12(1):7666 2022 [PMID: 35538182]
  51. Her PH, Saeed S, Tram KH, Bhatnagar SR. Novel mobility index tracks COVID-19 transmission following stay-at-home orders Scientific reports 12(1):7654 2022 [PMID: 35538129]
  52. Berec L, Levínský R, Weiner J, Šmíd M, Neruda R, Vidnerová P, Suchopárová G. Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose Scientific reports 12(1):7638 2022 [PMID: 35538118]
  53. Adams CD, Tielbeek JJ, Boutwell BB. Shared genomic architectures of COVID-19 and antisocial behavior Translational psychiatry 12(1):193 2022 [PMID: 35538069]
  54. Lee J, Kim D, Byun J, Wu Y, Park J, Oh YK. In vivo fate and intracellular trafficking of vaccine delivery systems Advanced drug delivery reviews :114325 2022 [PMID: 35550392]
  55. Pitts J, Li J, Perry JK, Du Pont V, Riola N, Rodriguez L, Lu X, Kurhade C, Xie X, Camus G, Manhas S, Martin R, Shi PY, Cihlar T, Porter DP, Mo H, Maiorova E, Bilello JP. Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants Antimicrobial agents and chemotherapy :e0022222 2022 [PMID: 35532238]
  56. Tu K, Sarkadi Kristiansson R, Gronsbell J, de Lusignan S, Flottorp S, Goh LH, Hallinan CM, Hoang U, Kang SY, Kim YS, Li Z, Ling ZJ, Manski-Nankervis JA, Ng APP, Pace WD, Wensaas KA, Wong WC, Stephenson E. Changes in primary care visits arising from the COVID-19 pandemic: an international comparative study by the International Consortium of Primary Care Big Data Researchers (INTRePID) BMJ open 12(5):e059130 2022 [PMID: 35534063]
  57. Sassi MB, Ferjani S, Mkada I, Arbi M, Safer M, Elmoussi A, Abid S, Souiai O, Gharbi A, Tejouri A, Gaies E, Eljabri H, Ayed S, Hechaichi A, Daghfous R, Gouider R, Khelil JB, Kharrat M, Kacem I, Alya NB, Benkahla A, Trabelsi S, Boubaker IB. Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :105300 2022 [PMID: 35552003]
  58. Corey KB, Koo G, Phillips EJ. Adverse Events and Safety of SARS-Cov2 Vaccines: What's New and What's Next The journal of allergy and clinical immunology. In practice 2022 [PMID: 35550878]
  59. Kalantari Y, Aryanian Z, Mirahmadi SM, Alilou S, Hatami P, Goodarzi A. A systematic review on COVID-19 vaccination and cosmetic filler reactions: A focus on case studies and original articles Journal of cosmetic dermatology 2022 [PMID: 35534886]
  60. Corona G, Vena W, Pizzocaro A, Pallotti F, Paoli D, Rastrelli G, Baldi E, Cilloni N, Gacci M, Semeraro F, Salonia A, Minhas S, Pivonello R, Sforza A, Vignozzi L, Isidori AM, Lenzi A, Maggi M, Lombardo F. Andrological effects of SARS-Cov-2 infection: a systematic review and meta-analysis Journal of endocrinological investigation 2022 [PMID: 35527294]
  61. Myers LC, Kipnis P, Greene J, Lawson B, Escobar GJ, Fireman BH, Klein NP, Liu VX. Adults hospitalized with breakthrough COVID-19 have lower mortality than matched unvaccinated adults Journal of internal medicine 2022 [PMID: 35531712]
  62. Finsterer J, Matovu D. Consider Transverse Myelitis as a Complication of a SARS-CoV-2 Vaccination Journal of Korean medical science 37(18):e150 2022 [PMID: 35535377]
  63. Kianpour M, Akbarian M, Uversky VN. Nanoparticles for Coronavirus Control Nanomaterials (Basel, Switzerland) 12(9) 2022 [PMID: 35564311]
  64. Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies Nature biotechnology 2022 [PMID: 35534554]
  65. Lustig Y, Gonen T, Meltzer L, Gilboa M, Indenbaum V, Cohen C, Amit S, Jaber H, Doolman R, Asraf K, Rubin C, Fluss R, Mendelson E, Freedman L, Regev-Yochay G, Kreiss Y. Superior immunogenicity and effectiveness of the third compared to the second BNT162b2 vaccine dose Nature immunology 2022 [PMID: 35534723]
  66. Gilliland S, Alber S, Tregear H, Hennigan A, Weitzel N. Year in Review 2021: Noteworthy Literature in Cardiothoracic Critical Care Seminars in cardiothoracic and vascular anesthesia :10892532221100663 2022 [PMID: 35533191]
  67. Ceballo Y, López A, González CE, Ramos O, Andújar I, Martínez RU, Hernández A. Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice Molecular biology reports 2022 [PMID: 35526244]
  68. Ssentongo P, Ssentongo AE, Voleti N, Groff D, Sun A, Ba DM, Nunez J, Parent LJ, Chinchilli VM, Paules CI. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis BMC infectious diseases 22(1):439 2022 [PMID: 35525973]
  69. Fansher M, Adkins TJ, Lalwani P, Boduroglu A, Carlson M, Quirk M, Lewis RL, Shah P, Zhang H, Jonides J. Icon arrays reduce concern over COVID-19 vaccine side effects: a randomized control study Cognitive research: principles and implications 7(1):38 2022 [PMID: 35524896]
  70. Piñana JL, López-Corral L, Martino R, Vazquez L, Pérez A, Martin-Martin G, Gago B, Sanz-Linares G, Sanchez-Salinas A, Villalon L, Conesa-Garcia V, Olave MT, Corona M, Marcos-Corrales S, Tormo M, Hernández-Rivas JÁ, Montoro J, Rodriguez-Fernandez A, Risco-Gálvez I, Rodríguez-Belenguer P, Hernandez-Boluda JC, García-Cadenas I, Ruiz-García M, Muñoz-Bellido JL, Solano C, Cedillo Á, Sureda A, Navarro D. SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders Journal of hematology & oncology 15(1):54 2022 [PMID: 35526045]
  71. Sah MK, Singh BM, Sinha P, Devkota P, Yadav SK, Shrestha J, Shrestha A. Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports Journal of medical case reports 16(1):182 2022 [PMID: 35524323]
  72. Mizuno T, Takahashi R, Kamiyama T, Suzuki A, Suzuki M. Neuroleptic Malignant Syndrome with Adrenal Insufficiency After BNT162b2 COVID-19 Vaccination in a Man Taking Valproate: A Case Report The American journal of case reports 23:e936217 2022 [PMID: 35514081]
  73. Brinkley E, Mack CD, Albert L, Knuth K, Reynolds MW, Toovey S, Dreyer NA. COVID-19 Vaccinations in Pregnancy: Comparative Evaluation of Acute Side Effects and Self-Reported Impact on Quality of Life between Pregnant and Non-pregnant Women in the United States American journal of perinatology 2022 [PMID: 35523212]
  74. Lees M, Hodson N, Tinline-Goodfellow CT, Fung H, Elia A, Moore DR. Challenges for rapamycin repurposing as a potential therapeutic candidate for COVID-19: implications for skeletal muscle metabolic health in older persons American journal of physiology. Endocrinology and metabolism 2022 [PMID: 35521831]
  75. Al Saedi A, Kirk B, Iuliano S, Zanker J, Vogrin S, Jayaram L, Thomas S, Golding C, Navarro-Perez D, Marusic P, Leng S, Nanan R, Duque G. Effects of 3 months of multi-nutrient supplementation on the immune system and muscle and respiratory function of older adults in aged care (The Pomerium Study): protocol for a randomised controlled trial BMJ open 12(5):e059075 2022 [PMID: 35523505]
  76. Zürcher K, Abela IA, Stange M, Dupont C, Mugglin C, Egli A, Trkola A, Egger M, Fenner L. Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2022 [PMID: 35522980]
  77. Ghosh K, Chattopadyay B, Maity T, Acharya A. A Multi-dimensional Review on Severe Acute Respiratory Syndrome CoronaVirus-2 Current pharmaceutical biotechnology 2022 [PMID: 35524656]
  78. Dykema AG, Zhang B, Woldemeskel BA, Garliss CC, Rashid R, Westlake T, Zhang L, Zhang J, Cheung LS, Caushi JX, Pardoll DM, Cox AL, Ji H, Smith KN, Blankson JN. SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection EBioMedicine 80:104048 2022 [PMID: 35533495]
  79. Braun AS, Feil K, Reiser E, Weiss G, von Steuben T, Pinggera GM, Köhn FM, Toth B. Corona and Reproduction, or Why the Corona Vaccination Does Not Result in Infertility Geburtshilfe und Frauenheilkunde 82(5):490-500 2022 [PMID: 35528190]
  80. Sourouni M, Braun J, Oelmeier K, Möllers M, Willy D, Hennies MT, Köster HA, Pecks U, Klockenbusch W, Schmitz R. Assessment of Neonatal Cord Blood SARS-CoV-2 Antibodies after COVID-19 Vaccination in Pregnancy: A Prospective Cohort Study Geburtshilfe und Frauenheilkunde 82(5):510-516 2022 [PMID: 35528187]
  81. Oberemok VV, Andreeva OA, Laikova KV, Novikov IA, Kubyshkin AV. Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond Inflammation research : official journal of the European Histamine Research Society ... [et al.] 2022 [PMID: 35523969]
  82. Hayashi R, Takami Y, Fujigaki H, Amano K, Sakurai Y, Akita K, Yamana K, Maekawa A, Saito K, Takagi Y. Effects of Cardiopulmonary Bypass on IgG Antibody Titers after SARS-CoV2 Vaccination Interactive cardiovascular and thoracic surgery 2022 [PMID: 35521991]
  83. Khan IA, Zaid MB, Gold PA, Austin MS, Parvizi J, Bedard NA, Jevsevar DS, Hannon CP, Fillingham YA. Making a Joint Decision Regarding The Timing of Surgery For Elective Arthroplasty Surgery After Being Infected With COVID-19: A Systematic Review The Journal of arthroplasty 2022 [PMID: 35533820]
  84. Prasad N, Derado G, Nanduri SA, Reses HE, Dubendris H, Wong E, Soe MM, Li Q, Dollard P, Bagchi S, Edwards J, Shang N, Budnitz D, Bell J, Verani JR, Benin A, Link-Gelles R, Jernigan J, Pilishvili T. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022 MMWR. Morbidity and mortality weekly report 71(18):633-637 2022 [PMID: 35511708]
  85. Palomares Cabeza V, Kummer LYL, Wieske L, Hagen RR, Duurland M, Konijn VAL, van Dam KPJ, Stalman EW, van de Sandt CE, Boekel L, Verstegen NJM, Steenhuis M, Rispens T, Tas SW, Wolbink G, Killestein J, Kuijpers TW, van Ham SM, Eftimov F, Brinke AT, van Kempen ZLE. Longitudinal T-Cell Responses After a Third SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis on Ocrelizumab or Fingolimod Neurology(R) neuroimmunology & neuroinflammation 9(4) 2022 [PMID: 35523569]
  86. Hijano DR, Hoffman JM, Tang L, Schultz-Cherry SL, Thomas PG, Hakim H, Webby RJ, Hayden RT, Gaur AH. An adaptive, asymptomatic SARS-CoV-2 workforce screening program providing real-time, actionable monitoring of the COVID-19 pandemic PloS one 17(5):e0268237 2022 [PMID: 35522615]
  87. Wu Q, Wang C, Jing Q, Lu J, Liang B, Liu L, Wu J, Yu Q, Deng X, Zhang Z. Follow-up of patients with COVID-19 by the Delta variant after hospital discharge in Guangzhou, Guandong, China Revista do Instituto de Medicina Tropical de Sao Paulo 64:e31 2022 [PMID: 35544909]
  88. Bangaru S, Antanasijevic A, Kose N, Sewall LM, Jackson AM, Suryadevara N, Zhan X, Torres JL, Copps J, de la Peña AT, Crowe JE Jr, Ward AB. Structural mapping of antibody landscapes to human betacoronavirus spike proteins Science advances 8(18):eabn2911 2022 [PMID: 35507649]
  89. Kim D, Keskinocak P, Pekgün P, Yildirim İ. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants Scientific reports 12(1):7493 2022 [PMID: 35523832]
  90. Chen KK, Huang DT, Huang LM. SARS-CoV-2 Variants - Evolution, Spike Protein, and Vaccines Biomedical journal 2022 [PMID: 35526825]
  91. Ding Z, Chen T, Lan J, Wong G. Application of animal models to compare and contrast the virulence of current and future potential SARS-CoV-2 variants Biosafety and health 2022 [PMID: 35528630]
  92. Ustianowski A. Why covid vaccine studies are still needed BMJ (Clinical research ed.) 377:o1135 2022 [PMID: 35512803]
  93. McGrail J, Martín-Banderas L, Durán-Lobato M. Cannabinoids as Emergent Therapy Against COVID-19 Cannabis and cannabinoid research 2022 [PMID: 35512732]
  94. Cascio Rizzo A, Giussani G, Agostoni EC. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature Cerebrovascular diseases (Basel, Switzerland) :1-13 2022 [PMID: 35512656]
  95. Rangsrisaeneepitak V, Porntharukchareon T, Dechates B, Sirisreetreerux S, Tawinprai K. Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine Diabetology international :1-7 2022 [PMID: 35528950]
  96. Ekobena P, Rothuizen LE, Bedussi F, Guilcher P, Meylan S, Ceschi A, Girardin F, Dao K. Four cases of audio-vestibular disorders related to immunisation with SARS-CoV-2 mRNA vaccines International journal of audiology :1-5 2022 [PMID: 35510657]
  97. Simsek M, Yasin AI, Besiroglu M, Topcu A, Sucuoglu Isleyen Z, Seker M, Turk HM. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer Journal of medical virology 2022 [PMID: 35513241]
  98. Rubin EJ, Baden LR, Morrissey S. Audio Interview: Do We Need New Covid-19 Vaccines? The New England journal of medicine 386(18):e52 2022 [PMID: 35507489]
  99. Belik M, Jalkanen P, Lundberg R, Reinholm A, Laine L, Väisänen E, Skön M, Tähtinen PA, Ivaska L, Pakkanen SH, Häkkinen HK, Ortamo E, Pasternack A, Ritvos MA, Naves RA, Miettinen S, Sironen T, Vapalahti O, Ritvos O, Österlund P, Kantele A, Lempainen J, Kakkola L, Kolehmainen P, Julkunen I. Comparative analysis of COVID-19 vaccine responses and third booster dose-induced neutralizing antibodies against Delta and Omicron variants Nature communications 13(1):2476 2022 [PMID: 35513437]
  100. Zhu DY, Gorman MJ, Yuan D, Yu J, Mercado NB, McMahan K, Borducchi EN, Lifton M, Liu J, Nampanya F, Patel S, Peter L, Tostanoski LH, Pessaint L, Van Ry A, Finneyfrock B, Velasco J, Teow E, Brown R, Cook A, Andersen H, Lewis MG, Lauffenburger DA, Barouch DH, Alter G. Defining the determinants of protection against SARS-CoV-2 infection and viral control in a dose-down Ad26.CoV2.S vaccine study in nonhuman primates PLoS biology 20(5):e3001609 2022 [PMID: 35512013]
  101. Langel SN, Johnson S, Martinez CI, Tedjakusuma SN, Peinovich N, Dora EG, Kuehl PJ, Irshad H, Barrett EG, Werts A, Tucker SN. Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model Science translational medicine :eabn6868 2022 [PMID: 35511920]
  102. Ramot Y, Kronfeld N, Ophir Y, Ezov N, Friedman S, Saloheimo M, Vitikainen M, Ben-Artzi H, Avigdor A, Tchelet R, Valbuena Crespo N, Emalfarb M, Nyska A. Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 <i>Thermothelomyces Heterothallica</i> Protein Expression Platform Toxicologic pathology :1926233221090518 2022 [PMID: 35514116]
  103. Gasteiger N, Gasteiger C, Vedhara K, Broadbent E. Characteristics associated with the willingness to receive a COVID-19 vaccine and an exploration of the general public's perceptions: A mixed-methods approach Vaccine 2022 [PMID: 35562194]
  104. Ospelnikova TP, Levitskaya DS, Kolodyazhnaya LV, Shitova AD, Osiptsov VN, Arifullina LR, Kryukova NO, Pakhomov DV, Khromova EA, Baranova IA, Chuchalin AG, Kostinov MP, Svitich OA. [Biological activity of interferons in the novel coronavirus infection COVID-19] Voprosy virusologii 67(2):142-152 2022 [PMID: 35521987]
  105. Kang CK, Shin HM, Choe PG, Park J, Hong J, Seo JS, Lee YH, Chang E, Kim NJ, Kim M, Kim YW, Kim HR, Lee CH, Seo JY, Park WB, Oh MD. Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection BMC medicine 20(1):181 2022 [PMID: 35508998]
  106. Rahman M, Islam R, Shohag S, Hossain E, Shah M, Shuvo SK, Khan H, Chowdhury AR, Bulbul IJ, Hossain S, Sultana S, Ahmed M, Akhtar MF, Saleem A, Rahman H. Multifaceted role of natural sources for COVID-19 pandemic as marine drugs Environmental science and pollution research international 2022 [PMID: 35507224]
  107. Girkin JLN, Maltby S, Bartlett NW. Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell European respiratory review : an official journal of the European Respiratory Society 31(164) 2022 [PMID: 35508333]
  108. Huttler A, Koelper N, Mainigi M, Gracia C, Senapati S. Impact of the COVID-19 pandemic on perception of planned oocyte cryopreservation in the United States F&S reports 2022 [PMID: 35529036]
  109. Faour-Klingbeil D, Osaili TM, Al-Nabulsi AA, O Taybeh A, Jemni M, Todd ECD. How has public perception of food safety and health risks changed a year after the pandemic and vaccines roll out? Food control :109073 2022 [PMID: 35531071]
  110. Roy A, Verma N, Singh S, Pradhan P, Taneja S, Singh M. Immune-mediated liver injury following COVID-19 vaccination: A systematic review Hepatology communications 2022 [PMID: 35507736]
  111. Laracy JC, Robilotti EV, Yan J, Lucca A, Aslam A, Babady NE, Kamboj M. Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant Infection control and hospital epidemiology :1-3 2022 [PMID: 35506167]
  112. Wu F, Yuan Y, Deng Z, Yin D, Shen Q, Zeng J, Xie Y, Xu M, Yang M, Jiang S, Zhang C, Lu H, Sun C. Acceptance of COVID-19 booster vaccination based on the protection motivation theory: A cross-sectional study in China Journal of medical virology 2022 [PMID: 35506329]
  113. Mun KH, Jang H, Jeong H, Choi J, Lee JW, Kim AR, Kim SH, Kim SS, Kwon D, Minn D, Park Q. Comparison of the Prevalence of Antibodies to SARS-CoV-2 in 9954 Recruits in the Korean Army Training Center with the General Korean Population of Equivalent Age Between September and November, 2020 Medical science monitor : international medical journal of experimental and clinical research 28:e934926 2022 [PMID: 35505583]
  114. Hager KJ, Pérez Marc G, Gobeil P, Diaz RS, Heizer G, Llapur C, Makarkov AI, Vasconcellos E, Pillet S, Riera F, Saxena P, Geller Wolff P, Bhutada K, Wallace G, Aazami H, Jones CE, Polack FP, Ferrara L, Atkins J, Boulay I, Dhaliwall J, Charland N, Couture MMJ, Jiang-Wright J, Landry N, Lapointe S, Lorin A, Mahmood A, Moulton LH, Pahmer E, Parent J, Séguin A, Tran L, Breuer T, Ceregido MA, Koutsoukos M, Roman F, Namba J, D'Aoust MA, Trepanier S, Kimura Y, Ward BJ. Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 Vaccine The New England journal of medicine 2022 [PMID: 35507508]
  115. Dai L, Gao L, Tao L, Hadinegoro SR, Erkin M, Ying Z, He P, Girsang RT, Vergara H, Akram J, Satari HI, Khaliq T, Sughra U, Celi AP, Li F, Li Y, Jiang Z, Dalimova D, Tuychiev J, Turdikulova S, Ikram A, Flores Lastra N, Ding F, Suhardono M, Fadlyana E, Yan J, Hu Z, Li C, Abdurakhmonov IY, Gao GF. Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults The New England journal of medicine 2022 [PMID: 35507481]
  116. Routledge I, Takahashi S, Epstein A, Hakim J, Janson O, Turcios K, Vinden J, Risos JT, Baniqued MR, Pham L, Di Germanio C, Busch M, Kushel M, Greenhouse B, Rodríguez-Barraquer I. Using sero-epidemiology to monitor disparities in vaccination and infection with SARS-CoV-2 Nature communications 13(1):2451 2022 [PMID: 35508478]
  117. Aldrete-Cortez V, Bobadilla L, Tafoya SA, Gonzalez-Carpinteiro A, Nava F, Viñals C, Alvarado E, Mendizabal-Espinosa R, Gómez-López ME, Ramirez-Garcia LA, Perez-Miguel A. Infants prenatally exposed to SARS-CoV-2 show the absence of fidgety movements and are at higher risk for neurological disorders: A comparative study PloS one 17(5):e0267575 2022 [PMID: 35507630]
  118. Dorosti H, Zarei M, Nezafat N. Proteome Exploration of human coronaviruses for Identifying Novel vaccine candidate: A Hierarchical Subtractive Genomics and Reverse Vaccinology Approach Recent patents on biotechnology 2022 [PMID: 35538841]
  119. Fauvel C, Trimaille A, Weizman O, Pezel T, Mika D, Waldmann V, Cohen A, Bonnet G. Cardiovascular manifestations secondary to COVID-19: A narrative review Respiratory medicine and research 81:100904 2022 [PMID: 35525097]
  120. D'acremont V, Chambaz G, Genton B. [Covid-19 crisis: testing and vaccination in the light of diminishing returns] Revue medicale suisse 18(780):904-908 2022 [PMID: 35510283]
  121. Romano A, Parrinello NL, Barchitta M, Manuele R, Puglisi F, Maugeri A, Barbato A, Triolo AM, Giallongo C, Tibullo D, La Ferla L, Botta C, Siragusa S, Iacobello C, Montineri A, Volti GL, Agodi A, Palumbo GA, Di Raimondo F. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection Scientific reports 12(1):7237 2022 [PMID: 35508575]
  122. Hausfater P, Boutolleau D, Lacombe K, Beurton A, Dumont M, Constantin JM, Ghosn J, Combes A, Cury N, Guedj R, Djibré M, Bompard R, Mazerand S, Pourcher V, Gimeno L, Marois C, Teyssou E, Marcelin AG, Hajage D, Tubach F. Cumulative incidence of SARS-CoV-2 infection and associated risk factors among frontline health care workers in Paris: the SEROCOV cohort study Scientific reports 12(1):7211 2022 [PMID: 35508515]
  123. Zhu H, Wang X, Zhang F, Zhu Y, Du MR, Tao ZW, Sun C, Ma HT, Li YD, Liang GQ, Ren J, Feng BL, Jiang F. Evaluation of inactivated COVID-19 vaccine on semen parameters in reproductive-age males: a retrospective cohort study Asian journal of andrology 2022 [PMID: 35532560]
  124. Abhishek A, Boyton RJ, McKnight Á, Coates L, Bluett J, Barber VS, Cureton L, Francis A, Appelbe D, Eldridge L, Julier P, Peckham N, Valdes AM, Rombach I, Altmann DM, Nguyen-Van-Tam J, Williams HC, Cook JA. Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study) BMJ open 12(5):e062599 2022 [PMID: 35504634]
  125. Cantoni D, Mayora-Neto M, Thakur N, Elrefaey AME, Newman J, Vishwanath S, Nadesalingam A, Chan A, Smith P, Castillo-Olivares J, Baxendale H, Charleston B, Heeney J, Bailey D, Temperton N. Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients Communications biology 5(1):409 2022 [PMID: 35505237]
  126. Slomski A. Studies Examine Risk of Hearing Loss After COVID-19 Vaccination JAMA 327(17):1641 2022 [PMID: 35503358]
  127. Markosian C, Staquicini DI, Dogra P, Dodero-Rojas E, Lubin JH, Tang FHF, Smith TL, Contessoto VG, Libutti SK, Wang Z, Cristini V, Khare SD, Whitford PC, Burley SK, Onuchic JN, Pasqualini R, Arap W. Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection Molecular biology and evolution 2022 [PMID: 35511693]
  128. Deval J, Gurard-Levin ZA. Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex Molecules (Basel, Switzerland) 27(9) 2022 [PMID: 35566268]
  129. Dong L, Bogart LM, Gandhi P, Aboagye JB, Ryan S, Serwanga R, Ojikutu BO. A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake PloS one 17(5):e0268020 2022 [PMID: 35503797]
  130. Finsterer J. Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab Reumatismo 74(1) 2022 [PMID: 35506319]
  131. Maranini B, Ciancio G, Corazza M, Ruffilli F, Galoppini G, Govoni M. Erythema nodosum after COVID-19 vaccine Reumatismo 74(1) 2022 [PMID: 35506318]
  132. Maranini B, Ciancio G, Cultrera R, Govoni M. Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer Reumatismo 74(1) 2022 [PMID: 35506316]
  133. Sepehri B, Ghavami R, Mahmoudi F, Irani M, Ahmadi R, Moradi D. Identifying SARS-CoV-2 main protease inhibitors by applying the computer screening of a large database of molecules SAR and QSAR in environmental research :1-16 2022 [PMID: 35502579]
  134. Junker D, Dulovic A, Becker M, Wagner TR, Kaiser PD, Traenkle B, Kienzle K, Bunk S, Struemper C, Haeberle H, Schmauder K, Ruetalo N, Malek N, Althaus K, Koeppen M, Rothbauer U, Walz JS, Schindler M, Bitzer M, Göpel S, Schneiderhan-Marra N. COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants Scientific reports 12(1):7168 2022 [PMID: 35505068]
  135. Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects Signal transduction and targeted therapy 7(1):146 2022 [PMID: 35504917]
  136. Hall VG, Al-Alahmadi G, Solera JT, Marinelli T, Cardinal H, Prasad GVR, De Serres SA, Isaac D, Mainra R, Lamarche C, Sapir-Pichhadze R, Gilmour S, Matelski J, Humar A, Kumar D. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study Transplantation 2022 [PMID: 35502801]
  137. Bothun LS, Feeder SE, Poland GA. Readability of COVID-19 vaccine information for the general public Vaccine 2022 [PMID: 35534313]
  138. Leemans W, Antonis S, De Vooght W, Lemmens R, Van Damme P. Neuromuscular complications after COVID-19 vaccination: a series of eight patients Acta neurologica Belgica 2022 [PMID: 35499704]
  139. Yamanouchi Y, Maeda K, Shinoda Y, Majima M, Lee J, Inoue I, Maruyama Y, Kurabayashi H. Can outpatient rehabilitation be continued during the COVID-19 pandemic? A report from a Japanese regional medical university hospital Archives of rehabilitation research and clinical translation :100199 2022 [PMID: 35531050]
  140. Bwire G, Ario AR, Eyu P, Ocom F, Wamala JF, Kusi KA, Ndeketa L, Jambo KC, Wanyenze RK, Talisuna AO. The COVID-19 pandemic in the African continent BMC medicine 20(1):167 2022 [PMID: 35501853]
  141. Cuschieri S, Grech S, Grech V. A year of Covid-19 pandemic roller-coaster: The Malta experience, lessons learnt and the future Disaster medicine and public health preparedness :1-28 2022 [PMID: 35492029]
  142. Cuschieri S, Cuschieri A, Farrugia E, Diacono E, Balzan E, Grupetta M, Vella A, Cutajar C, Formosa M, Barbara M, Mintoff F, Shaw C, Fleri Soler S, Borg N, Pace G, Vella L, Pisani R, Attard Mallia T, Gouder M, Attard R, Grixti N, Scicluna M, Borda T, Bartolo K, Chircop R, Degabrielle Ferrante E, Mallia M, Attard M, Frendo N, Gatt G, Damato G, Riolo N, Muscat Baron L, Galea M, Grech E. A case for cross-border governance? A comparative trend assessment of COVID-19 transmission, vaccination, and outcomes among 35 nations in Europe across 18 months Disaster medicine and public health preparedness :1-49 2022 [PMID: 35492012]
  143. Hou PC, Huang HY, Lee JY, Hsu CK. Pyostomatitis vegetans following coronavirus disease 2019 vaccination in a patient with ulcerative colitis The Journal of dermatology 2022 [PMID: 35491619]
  144. Jung J, Lee J, Park H, Lim YJ, Kim EO, Park MS, Kim SH. Nosocomial Outbreak by Delta Variant From a Fully Vaccinated Patient Journal of Korean medical science 37(17):e133 2022 [PMID: 35502502]
  145. Lee H, Choi EH, Park YJ, Choe YJ. Short Term Impact of Coronavirus Disease 2019 Vaccination in Children in Korea Journal of Korean medical science 37(17):e124 2022 [PMID: 35502499]
  146. Dong S, Kong N, Zhang Y, Li Y, Sun D, Qin W, Zhai H, Zhai X, Yang X, Ye C, Ye M, Liu C, Yu L, Zheng H, Tong W, Yu H, Zhang W, Tong G, Shan T. TARDBP Inhibits Porcine Epidemic Diarrhea Virus Replication through Degrading Viral Nucleocapsid Protein and Activating Type I Interferon Signaling Journal of virology :e0007022 2022 [PMID: 35499322]
  147. Furukawa K, Tjan LH, Kurahashi Y, Sutandhio S, Nishimura M, Arii J, Mori Y. Assessment of Neutralizing Antibody Response Against SARS-CoV-2 Variants After 2 to 3 Doses of the BNT162b2 mRNA COVID-19 Vaccine JAMA network open 5(5):e2210780 2022 [PMID: 35532938]
  148. Prince T, Dong X, Penrice-Randal R, Randle N, Hartley C, Goldswain H, Jones B, Semple MG, Baillie JK, Openshaw PJM, Turtle L, Hughes GL, Anderson ER, Patterson EI, Druce J, Screaton G, Carroll MW, Stewart JP, Hiscox JA. Analysis of SARS-CoV-2 in Nasopharyngeal Samples from Patients with COVID-19 Illustrates Population Variation and Diverse Phenotypes, Placing the Growth Properties of Variants of Concern in Context with Other Lineages mSphere :e0091321 2022 [PMID: 35491827]
  149. Islam N, Sheils NE, Jarvis MS, Cohen K. Comparative effectiveness over time of the mRNA-1273 (Moderna) vaccine and the BNT162b2 (Pfizer-BioNTech) vaccine Nature communications 13(1):2377 2022 [PMID: 35501319]
  150. Niemi MEK, Daly MJ, Ganna A. The human genetic epidemiology of COVID-19 Nature reviews. Genetics 2022 [PMID: 35501396]
  151. Romozzi M, Rollo E, Quintieri P, Dono F, Evangelista G, Consoli S, Veleno L, Anzellotti F, Calvello C, Costa C, Servidei S, Calabresi P, Vollono C. Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022 [PMID: 35501537]
  152. Singh B, Eshaghian E, Chuang J, Covasa M. Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19? Nutrients 14(9) 2022 [PMID: 35565876]
  153. Maher DI, Hogarty D, Ben Artsi E. Acute onset ocular myasthenia gravis after vaccination with the Oxford-AstraZeneca COVID-19 vaccine Orbit (Amsterdam, Netherlands) :1-5 2022 [PMID: 35499172]
  154. Bicher M, Rippinger C, Zechmeister M, Jahn B, Sroczynski G, Mühlberger N, Santamaria-Navarro J, Urach C, Brunmeir D, Siebert U, Popper N. An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply PloS one 17(5):e0265957 2022 [PMID: 35499997]
  155. Yavarian J, Nejati A, Salimi V, Shafiei Jandaghi NZ, Sadeghi K, Abedi A, Sharifi Zarchi A, Gouya MM, Mokhtari-Azad T. Whole genome sequencing of SARS-CoV2 strains circulating in Iran during five waves of pandemic PloS one 17(5):e0267847 2022 [PMID: 35499994]
  156. Morales DX, Beltran TF, Morales SA. Gender, socioeconomic status, and COVID-19 vaccine hesitancy in the US: An intersectionality approach Sociology of health & illness 2022 [PMID: 35500003]
  157. Okyar Baş A, Hafizoğlu M, Akbiyik F, Güner Oytun M, Şahiner Z, Ceylan S, Ünsal P, Doğu BB, Cankurtaran M, Çakir B, Ünal S, Halil MG. Antibody response with SARS-CoV-2 inactivated vaccine (CoronaVac) in Turkish geriatric population Age and ageing 51(5) 2022 [PMID: 35524745]
  158. Hollinghurst J, Hollinghurst R, North L, Mizen A, Akbari A, Long S, Lyons RA, Fry R. COVID-19 risk factors amongst 14,786 care home residents: an observational longitudinal analysis including daily community positive test rates of COVID-19, hospital stays and vaccination status in Wales (UK) between 1 September 2020 and 1 May 2021 Age and ageing 51(5) 2022 [PMID: 35511729]
  159. Du Z, Yin J. Safety of an inactivated COVID-19 vaccine in patients with - wheat-dependent exercise-induced anaphylaxis Allergologia et immunopathologia 50(3):132-137 2022 [PMID: 35527667]
  160. Barrios Y, Franco A, Alava-Cruz C, Cuesta-Martin R, Camara C, Matheu V. Easy approach to detect cell immunity to COVID vaccines in common variable immunodeficiency patients Allergologia et immunopathologia 50(3):101-105 2022 [PMID: 35527662]
  161. Punjwani S, Khanna P, Jani C, Waston J, Behlau I. Aortic Mural Thrombosis Diagnosed After a Second Dose of mRNA-1273 SARS-CoV-2 Vaccine American journal of therapeutics 29(3):e358-e361 2022 [PMID: 35533327]
  162. Kovoor JG, Jacobsen JHW, Duncan J, Addo AA, Tivey DR, Babidge WJ, Penn D, Churchill J, Collinson TG, Kok J, Kelly S, Lu VH, Beavis VS, MacCormick AD, Kearney BJ, Gowans EJ, Hewett PJ, Hugh TJ, Woo HH, Padbury RT, Scott DA, Frydenberg M, Maddern GJ. Achieving safe surgery after COVID-19 vaccination ANZ journal of surgery 92(5):946-949 2022 [PMID: 35535005]
  163. Yoo KJ, Mehta A, Mak J, Bishai D, Chansa C, Patenaude B. COVAX and equitable access to COVID-19 vaccines Bulletin of the World Health Organization 100(5):315-328 2022 [PMID: 35521037]
  164. Yaladanda N, Mopuri R, Vavilala HP, Mutheneni SR. Modelling the impact of perfect and imperfect vaccination strategy against SARS CoV-2 by assuming varied vaccine efficacy over India Clinical epidemiology and global health 15:101052 2022 [PMID: 35535224]
  165. Lozano-Rodríguez R, Terrón-Arcos V, Montalbán-Hernández K, Casalvilla-Dueñas JC, Bergón-Gutierrez M, Pascual-Iglesias A, Quiroga JV, Aguirre LA, Pérez de Diego R, Vela-Olmo C, López-Morejón L, Martín-Quirós A, Del Balzo-Castillo Á, Peinado-Quesada MA, García-Garrido MA, Gómez-Lage L, Herrero-Benito C, Llorente-Fernández I, Martín-Miguel G, Torrejón M, Cubillos-Zapata C, Del Fresno C, Avendaño-Ortiz J, López-Collazo E. Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational study Clinical and translational medicine 12(5):e869 2022 [PMID: 35538923]
  166. Zumla A, Hui DSC. Editorial: Coronavirus disease 2019 (COVID-19) - advances in epidemiology, diagnostics, treatments, host-directed therapies, pathogenesis, vaccines, and ongoing challenges Current opinion in pulmonary medicine 28(3):163-165 2022 [PMID: 35551155]
  167. Miller E. Predicting the efficacy of new coronavirus vaccines - Are neutralising antibodies enough? EBioMedicine 79:104034 2022 [PMID: 35489231]
  168. de Bruin M, Suk JE, Baggio M, Blomquist SE, Falcon M, Forjaz MJ, Godoy-Ramirez K, Leurs M, Rodriguez-Blazquez C, Romay-Barja M, Uiters E, Kinsman J. Behavioural insights and the evolving COVID-19 pandemic Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18) 2022 [PMID: 35514309]
  169. Cheng SM, Mok CKP, Chan KC, Ng SS, Lam BH, Luk LL, Ko FW, Chen C, Yiu K, Li JK, Chan KK, Tsang LC, Poon LL, Hui DS, Peiris M. SARS-CoV-2 Omicron variant BA.2 neutralisation in sera of people with Comirnaty or CoronaVac vaccination, infection or breakthrough infection, Hong Kong, 2020 to 2022 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18) 2022 [PMID: 35514306]
  170. Björk J, Bonander C, Moghaddassi M, Rasmussen M, Malmqvist U, Inghammar M, Kahn F. COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants - surveillance results from southern Sweden, December 2021 to March 2022 Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27(18) 2022 [PMID: 35514304]
  171. Wu Wu A, Lubin JH, Olivas C, Zardecki C, Balogun M, Bacorn ML, Khare SD, Burley SK. Bioinformatics and 3D Structural Analysis of the Coronavirus Main Protease Active Site Diversity FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35560880]
  172. Chen MH, Tulp OL, Einstein GP. COVID-19: Implications Regarding the Properties and Behaviors of the Coronavirus Disease FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35557428]
  173. Velázquez Roig R, Rodríguez-Martínez JA. Development of DNA Aptamers Against Structural Proteins of SARS-CoV-2 FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35556568]
  174. Grimes LT 4th, Reichart TM. Synthesis of the transmembrane domain of the spike protein from SARS-CoV-2 using solid phase peptide synthesis and determination of its oligomerization state FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35556509]
  175. DeMarco V, Sine LC, Hintelmann T, Reardon S, Hicks MJ. Anti-CovidMicroRNA Therapy Blocksthe Expression of the SpikeGeneof SARS-CoV-2 FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35556485]
  176. Serviente C, Matias A, Erol ME, Calderone M, Layec G. The Influence of Covid-19-Based mRNA Vaccines on Measures of Conduit Artery and Microvascular Endothelial Function FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35556032]
  177. Cetin S. Structural Differences in SARS-Cov-2 Spike Proteins and their Effects FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555527]
  178. Canziani GA, Tang J, Nangarlia A, Zhang S, Fazloon-Hassen F, Taludker C, Connors J, Cusimano G, Bernui M, Bell M, Kutzler M, Haddad E, Cairns C, Chaiken I. Anti-S2 Protection in COVID-19 Infection and SARS-CoV-2 Spike Vaccination FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35554532]
  179. Del Carmen Vélez M, Ocasio M, Méndez MDM, Vélez J, Suarez E. Protease Activated Receptor-2 (PAR-2) Antagonist potentially ameliorates the SARS-CoV-2 virus-induced Inflammatory Storm FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35554294]
  180. Hayashi T. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and Hippopotamus FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35554087]
  181. Asghar N, Mumtaz H, Syed AA, Eqbal F, Maharjan R, Bamboria A, Shrehta M. Safety, efficacy, and immunogenicity of COVID-19 vaccines; a systematic review Immunological medicine :1-13 2022 [PMID: 35491898]
  182. Finsterer J. Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous Indian journal of ophthalmology 70(5):1864 2022 [PMID: 35502110]
  183. Panigrahi PK. Comment on: Central retinal vein occlusion after mRNA SARS-CoV-2 vaccination Indian journal of ophthalmology 70(5):1862 2022 [PMID: 35502108]
  184. Wagle AM, Wu BC, Gopal L, Sundar G. Necrosis of uveal melanoma post-COVID-19 vaccination Indian journal of ophthalmology 70(5):1837-1840 2022 [PMID: 35502089]
  185. Nahata H, Nagaraja H, Shetty R. A case of acute endothelial corneal transplant rejection following immunization with ChAdOx1 nCoV-19 coronavirus vaccine Indian journal of ophthalmology 70(5):1817-1818 2022 [PMID: 35502082]
  186. Mertens G, Lodder P, Smeets T, Duijndam S. Fear of COVID-19 predicts vaccination willingness 14 months later Journal of anxiety disorders 88:102574 2022 [PMID: 35512598]
  187. Senoo Y, Suzuki Y, Tsuda K, Tanimoto T, Takahashi K. Association between coronavirus disease morbidity and mortality rates and BCG vaccination policies in OECD countries. Authors' reply Journal of infection prevention 23(3):118-119 2022 [PMID: 35495105]
  188. Jama GM, Amin M, Hassaan A, Kaddour H. Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine The Journal of laryngology and otology 136(5):466-468 2022 [PMID: 35510490]
  189. Levine Z, Earn DJD. Face masking and COVID-19: potential effects of variolation on transmission dynamics Journal of the Royal Society, Interface 19(190):20210781 2022 [PMID: 35506215]
  190. Madhi SA, Moodley D, Hanley S, Archary M, Hoosain Z, Lalloo U, Louw C, Fairlie L, Fouche LF, Masilela MSL, Singh N, Grobbelaar C, Ahmed K, Benadé G, Bhikha S, Bhorat AE, Bhorat Q, Joseph N, Dheda K, Esmail A, Foulkes S, Goga A, Oommen Jose A, Kruger G, Kalonji DJ, Lalloo N, Lombaard JJ, Lombard Koen A, Kany Luabeya A, Mngqibisa R, Petrick FG, Pitsi A, Tameris M, Thombrayil A, Vollgraaff PL, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Fries L, Robertson A, Neal S, Cho I, Glenn GM, Shinde V. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial The lancet. HIV 9(5):e309-e322 2022 [PMID: 35489376]
  191. Sadeghalvad M, Mansourabadi AH, Noori M, Nejadghaderi SA, Masoomikarimi M, Alimohammadi M, Rezaei N. Recent developments in SARS-CoV-2 vaccines: A systematic review of the current studies Reviews in medical virology :e2359 2022 [PMID: 35491495]
  192. Laster AJ, Lam GK, Gladue HS, Kashif AA, Siceloff EP, Lackey VD, Robertson CR, Toci AL, Calabrese LH. Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? RMD open 8(1) 2022 [PMID: 35534054]
  193. Soysal Ç, Yılmaz E. The effect of COVID-19 vaccine on ovarian reserve Saudi medical journal 43(5):486-490 2022 [PMID: 35537728]
  194. Lau O, Vadlamudi NK. Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 25(5):717-730 2022 [PMID: 35500945]
  195. Yamamoto M, Tajiri K, Ayuzawa S, Ieda M. Pathological Findings of Clinically Suspected Myocarditis Temporally Associated with COVID-19 Vaccination European journal of heart failure 2022 [PMID: 35488842]
  196. Saharia KK, Husson JS, Niederhaus SV, Iraguha T, Avila SV, Yoo YJ, Hardy NM, Fan X, Omili D, Crane A, Carrier A, Xie WY, Vander Mause E, Hankey K, Bauman S, Lesho P, Mannuel HD, Ahuja A, Mathew M, Avruch J, Baddley J, Goloubeva O, Shetty K, Dahiya S, Rapoport AP, Luetkens T, Atanackovic D. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine Clinical & translational immunology 11(5):e1391 2022 [PMID: 35505864]
  197. Radosław T, Dariusz D. Data on COVID-19 vaccination intention and its predictors in Poland Data in brief 42:108227 2022 [PMID: 35530365]
  198. Kamegai K, Iwamoto N, Togano T, Maeda K, Takamatsu Y, Miyazato Y, Ishikane M, Mizokami M, Sugiyama M, Iida S, Miyamoto S, Suzuki T, Ohmagari N. A Fatal Breakthrough Coronavirus Disease 2019 Case Following Bendamustine-Rituximab Therapy International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 [PMID: 35500795]
  199. Yoshimura Y, Sasaki H, Miyata N, Miyazaki K, Okudela K, Tateishi Y, Hayashi H, Kawana-Tachikawa A, Iwashita H, Maeda K, Ihama Y, Hatayama Y, Ryo A, Tachikawa N. An autopsy case of COVID-19-like acute respiratory distress syndrome after mRNA-1273 SARS-CoV-2 vaccination International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 [PMID: 35500794]
  200. Banerjee S, Wang X, Du S, Zhu C, Jia Y, Wang Y, Cai Q. Comprehensive role of SARS-CoV-2 spike glycoprotein in regulating host signaling pathway Journal of medical virology 2022 [PMID: 35488404]
  201. Bekci T, Cakir IM, Aslan S. Unilateral parotitis following mRNA coronavirus disease 2019 vaccination Revista da Sociedade Brasileira de Medicina Tropical 55:e00592022 2022 [PMID: 35522802]
  202. Nuñez DF, Leon L, Garcia AM, Arce JIC, Mucientes A, Gutierrez-Fernandez B, Rodriguez L, Cristóbal IPS, Álvarez P, Prada CM, Abasolo L. Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study Therapeutic advances in musculoskeletal disease 14:1759720X221090296 2022 [PMID: 35510167]
  203. Shrestha R, Shrestha S, Sapkota B, Khanal S, Kc B. Challenges Faced by Hospital Pharmacists in Low-Income Countries Before COVID-19 Vaccine Roll-Out: Handling Approaches and Implications for Future Pandemic Roles Turkish journal of pharmaceutical sciences 19(2):232-238 2022 [PMID: 35510364]
  204. Yusuf AJ, Abdullahi MI, Musa AM, Abubakar H, Amali AM, Nasir AH. Potential Inhibitors of SARS-CoV-2 from <i>Neocarya macrophylla</i> (Sabine) Prance ex F. White: Chemoinformatic and Molecular Modeling Studies for Three Key Targets Turkish journal of pharmaceutical sciences 19(2):202-212 2022 [PMID: 35510348]
  205. Fujioka Y, Kashiwagi S, Yoshida A, Satoh AO, Fujioka M, Amano M, Yamauchi Y, Ohba Y. A method for the generation of pseudovirus particles bearing SARS coronavirus spike protein in high yields Cell structure and function 2022 [PMID: 35491102]
  206. Dembek ZF, Lordo RA. Influence of Perfluoroalkyl Substances on Occurrence of Coronavirus Disease 2019 International journal of environmental research and public health 19(9) 2022 [PMID: 35564774]
  207. Auroux M, Laurent B, Coste B, Massy E, Mercier A, Durieu I, Confavreux CB, Lega JC, Mainbourg S, Coury F. Serological response to SARS-CoV-2 vaccination in patients with inflammatory rheumatic disease treated with disease modifying anti-rheumatic drugs: a cohort study and a systematic review with meta-analysis Joint bone spine :105380 2022 [PMID: 35490940]
  208. Mujwar S, Harwansh RK. <i>In silico</i> bioprospecting of taraxerol as a main protease inhibitor of SARS-CoV-2 to develop therapy against COVID-19 Structural chemistry :1-12 2022 [PMID: 35502321]
  209. Brady WJ, Chavez S, Gottlieb M, Liang SY, Carius B, Koyfman A, Long B. Clinical update on COVID-19 for the emergency clinician: Cardiac arrest in the out-of-hospital and in-hospital settings The American journal of emergency medicine 57:114-123 2022 [PMID: 35561501]
  210. Xu K, Gao P, Liu S, Lu S, Lei W, Zheng T, Liu X, Xie Y, Zhao Z, Guo S, Tang C, Yang Y, Yu W, Wang J, Zhou Y, Huang Q, Liu C, An Y, Zhang R, Han Y, Duan M, Wang S, Yang C, Wu C, Liu X, She G, Liu Y, Zhao X, Xu K, Qi J, Wu G, Peng X, Dai L, Wang P, Gao GF. Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2 Cell 2022 [PMID: 35568034]
  211. Nag A, Banerjee R, Paul S, Kundu R. Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study Computers in biology and medicine 146:105552 2022 [PMID: 35508082]
  212. Kabarkouhi Z, Mehrarya M, Gharehchelou B, Jalilian Z, Jalili R, Wintrasiri MN, Mozafari MR. Liposome, Nanoliposome and Allied Technologies in Covid-19 Vaccines: Key Roles and Functionalities Current drug delivery 2022 [PMID: 35490320]
  213. Clemente-Suárez VJ, Navarro-Jiménez E, Simón-Sanjurjo JA, Beltran-Velasco AI, Laborde-Cárdenas CC, Benitez-Agudelo JC, Bustamante-Sánchez Á, Tornero-Aguilera JF. Mis-Dis Information in COVID-19 Health Crisis: A Narrative Review International journal of environmental research and public health 19(9) 2022 [PMID: 35564714]
  214. Shi J, Zheng J, Zhang X, Tai W, Odle AE, Perlman S, Du L. RBD-mRNA vaccine induces broadly neutralizing antibodies against Omicron and multiple other variants and protects mice from SARS-CoV-2 challenge Translational research : the journal of laboratory and clinical medicine 2022 [PMID: 35489692]
  215. Pour Mohammad A, Mashayekhi F, Seirafianpour F, Gholizadeh Mesgarha M, Goodarzi A. COVID-19 and COVID-19 vaccine-related dermatological reactions: An interesting case series with a narrative review of the potential critical and non-critical mucocutaneous adverse effects related to virus, therapy, and the vaccination Clinical case reports 10(4):e05775 2022 [PMID: 35498347]
  216. Nakhaeizadeh M, Chegeni M, Adhami M, Sharifi H, Gohari MA, Iranpour A, Azizian M, Mashinchi M, Baneshi MR, Karamouzian M, Haghdoost AA, Jahani Y. Estimating the Number of COVID-19 Cases and Impact of New COVID-19 Variants and Vaccination on the Population in Kerman, Iran: A Mathematical Modeling Study Computational and mathematical methods in medicine 2022:6624471 2022 [PMID: 35495892]
  217. Liu L, Chen T, Zhou L, Sun J, Li Y, Nie M, Xiong H, Zhu Y, Xue W, Wu Y, Li T, Zhang T, Kong Z, Yu H, Zhang J, Gu Y, Zheng Q, Zhao Q, Xia N, Li S. A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice Frontiers in microbiology 13:854630 2022 [PMID: 35558112]
  218. Iwamuro A, Sasa T, Kawai T, Taguchi M, Izuhara M, Uegaito T, Shioji K. A 17-year-old male with acute myocarditis following mRNA-1273 vaccination in Japan Journal of cardiology cases 2022 [PMID: 35495897]
  219. Campanati A, Diotallevi F, Martina E, Radi G, Offidani A. Treatment of Moderate to Severe Psoriasis during the COVID-19 Pandemic: Lessons Learned and Opportunities Journal of clinical medicine 11(9) 2022 [PMID: 35566548]
  220. Gupta E, Mishra RK, Kumar Niraj RR. Identification of Potential Vaccine Candidates Against SARS-CoV-2 to Fight COVID-19: Reverse Vaccinology Approach JMIR bioinformatics and biotechnology 3(1):e32401 2022 [PMID: 35506029]
  221. Westendorf K, Žentelis S, Wang L, Foster D, Vaillancourt P, Wiggin M, Lovett E, van der Lee R, Hendle J, Pustilnik A, Sauder JM, Kraft L, Hwang Y, Siegel RW, Chen J, Heinz BA, Higgs RE, Kallewaard NL, Jepson K, Goya R, Smith MA, Collins DW, Pellacani D, Xiang P, de Puyraimond V, Ricicova M, Devorkin L, Pritchard C, O'Neill A, Dalal K, Panwar P, Dhupar H, Garces FA, Cohen CA, Dye JM, Huie KE, Badger CV, Kobasa D, Audet J, Freitas JJ, Hassanali S, Hughes I, Munoz L, Palma HC, Ramamurthy B, Cross RW, Geisbert TW, Menachery V, Lokugamage K, Borisevich V, Lanz I, Anderson L, Sipahimalani P, Corbett KS, Yang ES, Zhang Y, Shi W, Zhou T, Choe M, Misasi J, Kwong PD, Sullivan NJ, Graham BS, Fernandez TL, Hansen CL, Falconer E, Mascola JR, Jones BE, Barnhart BC. LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants Cell reports :110812 2022 [PMID: 35568025]
  222. Casasnovas JM, Margolles Y, Noriega MA, Guzmán M, Arranz R, Melero R, Casanova M, Corbera JA, Jiménez-de-Oya N, Gastaminza P, Garaigorta U, Saiz JC, Martín-Acebes MÁ, Fernández LÁ. Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron Frontiers in immunology 13:863831 2022 [PMID: 35547740]
  223. Xie MZ, Chen LY, Yang YN, Cui Y, Zhang SH, Zhao TS, Zhang WX, Du J, Cui FQ, Lu QB. Molecular Epidemiology of Herpangina Children in Tongzhou District, Beijing, China, During 2019-2020 Frontiers in medicine 9:822796 2022 [PMID: 35547223]
  224. van Vuuren CJJ, van Vuuren JMJ. Perspectives of healthcare workers in South Africa on COVID-19 vaccination passports Health SA = SA Gesondheid 27:1823 2022 [PMID: 35548060]
  225. Eliyahu-Levi D. Educators as Health and Education Mediators for African Asylum Seekers in Israel International journal of environmental research and public health 19(9) 2022 [PMID: 35564595]
  226. Bayou FD, Amare SN. Acceptance of COVID-19 Vaccine and Its Associated Factors Among Ethiopian Population: A Systematic Review Patient preference and adherence 16:1093-1103 2022 [PMID: 35492852]
  227. Alkis N, Baysal M. Subacute thyroiditis after SARS-CoV-2 BNT162b2 vaccine in a multiple myeloma patient SAGE open medical case reports 10:2050313X221091392 2022 [PMID: 35495295]
  228. Singh G, Howland T. Graves' Disease Following COVID-19 Vaccination Cureus 14(4):e24418 2022 [PMID: 35497078]
  229. Takano T, Morikawa M, Adachi Y, Kabasawa K, Sax N, Moriyama S, Sun L, Isogawa M, Nishiyama A, Onodera T, Terahara K, Tonouchi K, Nishimura M, Tomii K, Yamashita K, Matsumura T, Shinkai M, Takahashi Y. Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine Cell reports. Medicine :100631 2022 [PMID: 35545084]
  230. Fabricius G, Borzi RA, Caminos J, Grigera TS. Immunity acquired by a minority active fraction of the population could explain COVID-19 spread in Greater Buenos Aires (June-November 2020) Epidemiology and infection 150:e84 2022 [PMID: 35506178]
  231. Hurme A, Jalkanen P, Heroum J, Liedes O, Vara S, Melin M, Teräsjärvi J, He Q, Pöysti S, Hänninen A, Oksi J, Vuorinen T, Kantele A, Tähtinen PA, Ivaska L, Kakkola L, Lempainen J, Julkunen I. Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients Frontiers in immunology 13:869990 2022 [PMID: 35529867]
  232. Du Y, Zhang S, Zhang Z, Miah KM, Wei P, Zhang L, Zhu Y, Li Z, Ye F, Gill DR, Hyde SC, Wang Y, Zhao J. Intranasal Lentiviral Vector-Mediated Antibody Delivery Confers Reduction of SARS-CoV-2 Infection in Elderly and Immunocompromised Mice Frontiers in immunology 13:819058 2022 [PMID: 35529866]
  233. Li J, Jiang N, Zeng QL, Zhang Y, He X, Chu Y, Jin W, Liu Y, Shi W, Yang M, He W, Han Q, Ma L, Xu Y, Guo Y, Zhang L, Ji F. The Epidemiological, Clinical Features and Outcomes of Imported Chinese COVID-19 Patients Following Inactivated Vaccines Injection Infection and drug resistance 15:2115-2125 2022 [PMID: 35498630]
  234. Sauer N, Sałek A, Szlasa W, Ciecieląg T, Obara J, Gaweł S, Marciniak D, Karłowicz-Bodalska K. The Impact of COVID-19 on the Mental Well-Being of College Students International journal of environmental research and public health 19(9) 2022 [PMID: 35564484]
  235. Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, Steinmetz T, Agur T, Zingerman B, Herman-Edelstein M, Lichtenberg S, Ben-Zvi H, Bar-Haim E, Cohen H, Rotem S, Elia U, Margalit I, Zvi BR. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study Transplant international : official journal of the European Society for Organ Transplantation 35:10204 2022 [PMID: 35529596]
  236. Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis Trends in molecular medicine 2022 [PMID: 35537987]
  237. Kalejaiye TD, Bhattacharya R, Burt MA, Travieso T, Okafor AE, Mou X, Blasi M, Musah S. SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes Frontiers in cell and developmental biology 10:855340 2022 [PMID: 35517495]
  238. Wirsching S, Harder L, Heymanns M, Gröndahl B, Hilbert K, Kowalzik F, Meyer C, Gehring S. Long-Term, CD4<sup>+</sup> Memory T Cell Response to SARS-CoV-2 Frontiers in immunology 13:800070 2022 [PMID: 35514974]
  239. Mazzotta V, Cozzi-Lepri A, Colavita F, Lanini S, Rosati S, Lalle E, Mastrorosa I, Cimaglia C, Vergori A, Bevilacqua N, Lapa D, Mariano A, Bettini A, Agrati C, Piselli P, Girardi E, Castilletti C, Garbuglia AR, Vaia F, Nicastri E, Antinori A. Emulation of a Target Trial From Observational Data to Compare Effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for Early Treatment of Non-Hospitalized Patients With COVID-19 Frontiers in immunology 13:868020 2022 [PMID: 35514955]
  240. Mocci S, Littera R, Tranquilli S, Provenzano A, Mascia A, Cannas F, Lai S, Giuressi E, Chessa L, Angioni G, Campagna M, Firinu D, Del Zompo M, La Nasa G, Perra A, Giglio S. A Protective HLA Extended Haplotype Outweighs the Major COVID-19 Risk Factor Inherited From Neanderthals in the Sardinian Population Frontiers in immunology 13:891147 2022 [PMID: 35514995]
  241. Tian X, Zhang Y, He Z, Li S, Yan D, Zhu Z, Wan Y, Wang W. Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein Frontiers in immunology 13:875236 2022 [PMID: 35514964]
  242. Stefanski AL, Rincon-Arevalo H, Schrezenmeier E, Karberg K, Szelinski F, Ritter J, Chen Y, Jahrsdörfer B, Ludwig C, Schrezenmeier H, Lino AC, Dörner T. B Cell Characteristics at Baseline Predict Vaccination Response in RTX Treated Patients Frontiers in immunology 13:822885 2022 [PMID: 35514962]
  243. Yang L, Xiong H, Li X, Li Y, Zhou H, Lin X, Chan TF, Li R, Lai KP, Chen X. Network Pharmacology and Comparative Transcriptome Reveals Biotargets and Mechanisms of Curcumol Treating Lung Adenocarcinoma Patients With COVID-19 Frontiers in nutrition 9:870370 2022 [PMID: 35520289]
  244. Furuse Y. Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic International journal of environmental research and public health 19(9) 2022 [PMID: 35564325]
  245. Shaban MS, Mayr-Buro C, Meier-Soelch J, Albert BV, Schmitz ML, Ziebuhr J, Kracht M. Thapsigargin: key to new host-directed coronavirus antivirals? Trends in pharmacological sciences 2022 [PMID: 35534355]
  246. Stagnoli S, Peccati F, Connell SR, Martinez-Castillo A, Charro D, Millet O, Bruzzone C, Palazon A, Ardá A, Jiménez-Barbero J, Ereño-Orbea J, Abrescia NGA, Jiménez-Osés G. Assessing the Mobility of Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Glycans by Structural and Computational Methods Frontiers in microbiology 13:870938 2022 [PMID: 35495643]
  247. El Adam S, Zou M, Kim S, Henry B, Krajden M, Skowronski DM. SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada Open forum infectious diseases 9(5):ofac178 2022 [PMID: 35531384]
  248. Furian L, Russo FP, Zaza G, Burra P, Hartzell S, Bizzaro D, Di Bello M, Di Bella C, Nuzzolese E, Agnolon C, Florman S, Rana M, Lee JH, Kim Y, Maggiore U, Maltzman JS, Cravedi P. Differences in Humoral and Cellular Vaccine Responses to SARS-CoV-2 in Kidney and Liver Transplant Recipients Frontiers in immunology 13:853682 2022 [PMID: 35493446]
  249. Fu YS, Ho WY, Kang N, Tsai MJ, Wu J, Huang L, Weng CF. Pharmaceutical Prospects of Curcuminoids for the Remedy of COVID-19: Truth or Myth Frontiers in pharmacology 13:863082 2022 [PMID: 35496320]
  250. Khayyam M, Chuanmin S, Salim MA, Nizami A, Ali J, Ali H, Khan N, Ihtisham M, Anjum R. COVID-19 Vaccination Behavior Among Frontline Healthcare Workers in Pakistan: The Theory of Planned Behavior, Perceived Susceptibility, and Anticipated Regret Frontiers in psychology 13:808338 2022 [PMID: 35496249]
  251. Cunningham MR, Druen PB, Logsdon MC, Dreschler BW, Barbee AP, Carrico RL, Billings SW, Jones JW. The Psychology of Coronavirus Behavioral Health Mindset, Vaccination Receptivity, Customer Orientation and Community Public Service Frontiers in psychology 13:837365 2022 [PMID: 35496164]
  252. Kaznadzey A, Tutukina M, Bessonova T, Kireeva M, Mazo I. BNT162b2, mRNA-1273, and Sputnik V Vaccines Induce Comparable Immune Responses on a Par With Severe Course of COVID-19 Frontiers in immunology 13:797918 2022 [PMID: 35493476]
  253. Kaneko Y, Sugiyama A, Tanaka T, Fukui K, Taguchi A, Tatsuno K, Nakayama A, Koga K, Kishi Y, Daming W, Qian C, Xia F, He F, Zheng L, Yu Y, Wada Y, Wada Y, Kodama T, Kawamura T. The serological diversity of serum IgG/IgA/IgM against SARS-CoV-2 nucleoprotein, spike, and receptor-binding domain and neutralizing antibodies in patients with COVID-19 in Japan Health science reports 5(3):e572 2022 [PMID: 35509410]
  254. Stebbings R, Jones C, Cotton P, Armour G, Maguire S, Skellett V, Tang CM, Goodman J, Brady T, Takahashi V, Daunt A, Lapointe JM, Cohen TS. SARS-CoV-2 Spike Protein Expression <i>In Vitro</i> and Hematologic Effects in Mice Vaccinated With AZD1222 (ChAdOx1 nCoV-19) Frontiers in immunology 13:836492 2022 [PMID: 35493482]
  255. Hosseinian S, Powers K, Vasudev M, Palma AM, de Assis R, Jain A, Horvath P, Birring PS, Andary R, Au C, Chin B, Khalil G, Ventura J, Luu MK, Figueroa C, Obiero JM, Silzel E, Nakajima R, Gombrich WT, Jasinskas A, Zaldivar F, Schubl S, Felgner PL, Khan S. Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray Frontiers in immunology 13:817345 2022 [PMID: 35493473]
  256. Rodriguez-Sevilla JJ, Güerri-Fernádez R, Bertran Recasens B. Is There Less Alteration of Smell Sensation in Patients With Omicron SARS-CoV-2 Variant Infection? Frontiers in medicine 9:852998 2022 [PMID: 35492353]
  257. Wei J, Zhao M, Meng F, Chen J, Xu Y. Influence of Internet Celebrity Medical Experts on COVID-19 Vaccination Intention of Young Adults: An Empirical Study From China Frontiers in public health 10:887913 2022 [PMID: 35517646]
  258. Moro PL, Olson CK, Clark E, Marquez P, Strid P, Ellington S, Zhang B, Mba-Jonas A, Alimchandani M, Cragan J, Moore C. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021 Vaccine 2022 [PMID: 35489985]
  259. Hsieh CL, McLellan JS. Protein engineering responses to the COVID-19 pandemic Current opinion in structural biology 74:102385 2022 [PMID: 35533563]
  260. Islamoglu MS, Dokur M, Uysal BB, Gunduz M. Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine Turkish journal of emergency medicine 22(2):111-113 2022 [PMID: 35529027]
  261. Al-Midfai Y, Kujundzic W, Uppal S, Oakes D, Giezy S. Acute Multiple Sclerosis Exacerbation After Vaccination With the Johnson &amp; Johnson COVID-19 Vaccine: Novel Presentation and First Documented Case Report Cureus 14(4):e24017 2022 [PMID: 35547449]
  262. Yarlagadda H, Patel MA, Gupta V, Bansal T, Upadhyay S, Shaheen N, Jain R. COVID-19 Vaccine Challenges in Developing and Developed Countries Cureus 14(4):e23951 2022 [PMID: 35547442]
  263. Nasab S, Abhari S. Coronavirus disease 2019 vaccine and in vitro fertilization outcomes: myths vs. facts Fertility and sterility 2022 [PMID: 35525817]
  264. Salvagno GL, Henry BM, Pighi L, de NS, Lippi G. Total anti-SARS-CoV-2 antibodies measured 6 months after Pfizer-BioNTech COVID-19 vaccination in healthcare workers Journal of medical biochemistry 41(2):199-203 2022 [PMID: 35510202]
  265. Wireko FW, Khalafalla S, Jamshidi T, Mahgoub S. Septic and Crystal-Induced Arthritis (Pseudogout) Post-COVID-19 Vaccination Cureus 14(4):e23902 2022 [PMID: 35530843]
  266. Krylova O, Kazmi O, Wang H, Lam K, Logar-Henderson C, Gapanenko K. Estimating surge in COVID-19 cases, hospital resources and PPE demand with the interactive and locally-informed <i>COVID-19 Health System Capacity Planning Tool</i> International journal of population data science 5(4):1710 2020 [PMID: 35516164]
  267. Schmitz U, Swaminathan S. Discovery and development of oseltamivir at Gilead Sciences Antiviral therapy 27(2):13596535211067598 2022 [PMID: 35499178]
  268. Moreira HG, Oliveira Júnior MT, Valdigem BP, Martins CN, Polanczyk CA. Position Statement on Cardiovascular Safety of Vaccines Against COVID-19 - 2022 Arquivos brasileiros de cardiologia 118(4):789-796 2022 [PMID: 35508059]
  269. Gomes DA, Santos RR, Freitas P, Paiva MS, Ferreira J, Trabulo M. Acute Myocarditis Following mRNA COVID-19 Vaccine Arquivos brasileiros de cardiologia 118(4):783-786 2022 [PMID: 35508057]
  270. Karyagina AS, Gromov AV, Grunina TM, Lyaschuk AM, Poponova MS, Kleymenov DA, Strukova NV, Generalova MS, Ryazanova AV, Galushkina ZM, Dobrynina OY, Bolshakova TN, Sergeeva MV, Romanovskaya-Romanko EA, Krasilnikov IV, Subbotina ME, Lunin VG. Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization Biochemistry. Biokhimiia 87(4):319-330 2022 [PMID: 35527370]
  271. Khan JA, Satti L, Bizanjo M, Ather NA. Comparison of Clinical Characteristics and Outcome Between Vaccinated and Non-Vaccinated Patients of Covid-19 During the Delta Variant-Dominated Fourth Wave in a Tertiary Care Hospital in Karachi, Pakistan Cureus 14(4):e23726 2022 [PMID: 35509752]
  272. Pichler T, Frank T, Maier S, Batenhorst I, Albawi-Daltrozzo T, Harbeck N, Algül H, Heinemann V, Hermelink K, Mumm F, Dinkel A. [The views of cancer out-patients on the impact of the COVID-19 pandemic] Deutsche medizinische Wochenschrift (1946) 147(10):e41-e49 2022 [PMID: 35545063]
  273. Choi SW, Kim J, Lee JH, Kim SK, Lee SR, Kim SH, Chae HD. Hormone Therapy in the Era of the COVID-19 Pandemic: A Review Journal of menopausal medicine 28(1):1-8 2022 [PMID: 35534425]
  274. Ravichandran M, Tew HX, Prabhakaran G, Parasuraman S, Norazmi MN. Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine-A Research and Development Journey: Light at the End of a Long Tunnel The Malaysian journal of medical sciences : MJMS 29(2):1-7 2022 [PMID: 35528817]
  275. Harry AM, Edet CK, Ekanem NE, Kemdirim CJ, Uduak AE. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study The Nigerian postgraduate medical journal 29(2):89-95 2022 [PMID: 35488575]
  276. Kim C, Kang G, Kang SG, Lee H. COVID-19 outbreak response at a nursing hospital in South Korea in the post-vaccination era, including an estimation of the effectiveness of the first shot of the Oxford-AstraZeneca COVID-19 vaccine (ChAdOx1-S) Osong public health and research perspectives 13(2):114-122 2022 [PMID: 35538683]
  277. Mir I, Aamir S, Shah SRH, Shahid M, Amin I, Afzal S, Nawaz A, Khan MU, Idrees M. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic Osong public health and research perspectives 13(2):84-8100 2022 [PMID: 35538681]
  278. Luna CM. Impact of vaccination on the epidemiology and prognosis of pneumonia Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 35 Suppl 1:104-110 2022 [PMID: 35488837]
  279. Gabarin N, Arnold DM, Nazy I, Warkentin TE. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT) Seminars in hematology 59(2):89-96 2022 [PMID: 35512906]
  280. Schönborn L, Greinacher A. Longitudinal Aspects of VITT Seminars in hematology 59(2):108-114 2022 [PMID: 35512899]
  281. DiGiulio MB, Arbab R, Driscoll KP, Balmer DO J. COVID-19 Infection May Not Produce Lasting Immunity in Non-vaccinated Young Adults: A Retrospective Review of COVID-19 Antibody Data Cureus 14(3):e23698 2022 [PMID: 35509999]
  282. Oshida S, Akamatsu Y, Matsumoto Y, Suzuki T, Sasaki T, Kondo Y, Fujiwara S, Kashimura H, Kubo Y, Ogasawara K. Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports Surgical neurology international 13:117 2022 [PMID: 35509565]
  283. McLaughlin J. Immersive In-Person Field Courses during the Pandemic: Minimizing Risk while Maximizing Efficacy Bulletin of the Ecological Society of America :e01984 2022 [PMID: 35541694]
  284. Alessa MY, Aledili FJ, Alnasser AA, Aldharman SS, Al Dehailan AM, Abuseer HO, Almohammed Saleh AA, Alsalem HA, Alsadiq HM, Alsultan AS. The Side Effects of COVID-19 Vaccines and Its Association With ABO Blood Type Among the General Surgeons in Saudi Arabia Cureus 14(3):e23628 2022 [PMID: 35494934]
  285. Liu X, Chen M, Zhou Z, Chen D, Mo J, Liu J. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 47(3):344-351 2022 [PMID: 35545327]
  286. Shimamura Y, Anbo Y, Furuta Y. Post-vaccination Adverse Reactions After Receiving the Pfizer-BioNTech Coronavirus Disease 2019 Vaccines Among Healthcare Workers in Sapporo, Japan Cureus 14(3):e23549 2022 [PMID: 35494967]
  287. Chitty SA, Mobbs S, Rifkin BS, Stogner SW, Lewis MS, Betancourt J, DellaVolpe J, Abouzahr F, Wilhelm AM, Szerlip HM, Parikh A, Gaeta RM, Rivera I, Park C, Levi B, Anesi GL, Alcover KC, Arnold TB, Howard JT, Sharma K, Pratt KP, Stewart IJ, Chung KK. A Multicenter Evaluation of the Seraph 100 Microbind Affinity Blood Filter for the Treatment of Severe COVID-19 Critical care explorations 4(4):e0662 2022 [PMID: 35506015]
  288. Satué-Gracia EM, Vila-Córcoles A, de Diego-Cabanes C, Vila-Rovira A, Torrente-Fraga C, Gómez-Bertomeu F, Hospital-Guardiola I, Ochoa-Gondar O, Martín-Luján F. Susceptibility and risk of SARS-COV-2 infection among middle-aged and older adults in Tarragona area, Spain Medicina clinica (English ed.) 158(6):251-259 2022 [PMID: 35492428]
  289. Nguyen JL, Alfred T, Reimbaeva M, Malhotra D, Khan F, Swerdlow D, Angulo FJ. Population Attributable Fractions of Underlying Medical Conditions for Coronavirus Disease 2019 (COVID-19) Diagnosis and COVID-19 Hospitalizations, Ventilations, and Deaths Among Adults in the United States Open forum infectious diseases 9(5):ofac099 2022 [PMID: 35531382]
  290. Kiely P, Hoad VC, Seed CR, Gosbell IB. Severe Acute Respiratory Syndrome Coronavirus 2 and Blood Safety: An Updated Review Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 5:1-11 2022 [PMID: 35528142]
  291. Shareef LG, Fawzi Al-Hussainy A, Majeed Hameed S. COVID-19 vaccination hesitancy among Iraqi general population between beliefs and barriers: An observational study F1000Research 11:334 2022 [PMID: 35529280]
  292. Marcelin JR, Pettifor A, Janes H, Brown ER, Kublin JG, Stephenson KE. COVID-19 Vaccines and SARS-CoV-2 Transmission in the Era of New Variants: A Review and Perspective Open forum infectious diseases 9(5):ofac124 2022 [PMID: 35493113]
  293. Petzold A. Neuro-Ophthalmic Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Infection and Vaccination Asia-Pacific journal of ophthalmology (Philadelphia, Pa.) 11(2):196-207 2022 [PMID: 35533338]
  294. Somekh I, KhudaBukhsh WR, Root ED, Boker LK, Rempala G, Simões EAF, Somekh E. Quantifying the Population-Level Effect of the COVID-19 Mass Vaccination Campaign in Israel: A Modeling Study Open forum infectious diseases 9(5):ofac087 2022 [PMID: 35493128]
  295. Oboh MA, Omoleke S, Salami K. Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa The Pan African medical journal 41:148 2022 [PMID: 35519174]
  296. Lu J, Yin Q, Pei R, Zhang Q, Qu Y, Pan Y, Sun L, Gao D, Liang C, Yang J, Wu W, Li J, Cui Z, Wang Z, Li X, Li D, Wang S, Duan K, Guan W, Liang M, Yang X. Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants Virologica Sinica 2022 [PMID: 35527227]
  297. Chehade L, Zeitoun J, Lombe D, Irshad S, Hemelrijck MV, Canfell K, Sullivan R, Mukherji D. COVID-19 vaccination in patients with cancer, a rapid review Ecancermedicalscience 16:1355 2022 [PMID: 35510135]
  298. Stadtmüller M, Laubner A, Rost F, Winkler S, Patrasová E, Šimůnková L, Reinhardt S, Beil J, Dalpke AH, Yi B. Emergence and spread of a sub-lineage of SARS-CoV-2 Alpha variant B.1.1.7 in Europe, and with further evolution of spike mutation accumulations shared with the Beta and Gamma variants Virus evolution 8(1):veac010 2022 [PMID: 35494175]
  299. Alnima T, Mulder MMG, van Bussel BCT, Ten Cate H. COVID-19 Coagulopathy: From Pathogenesis to Treatment Acta haematologica :1-15 2022 [PMID: 35499460]
  300. Yelin D, Rozen-Zvi B, Yahav D, Ben-Dor N, Steinmetz T, Agur T, Zingerman B, Schneider S, Lichtenberg S, Ben-Zvi H, Mashraki T, Rahamimov R. SARS-CoV-2 antibody dynamics among kidney transplant recipients 3 months after BNT162b2 vaccination: a prospective cohort study Clinical kidney journal 15(5):992-998 2022 [PMID: 35498878]
  301. Joseph S, Kutty Narayanan A. Covid 19-the 21st Century Pandemic: The Novel Coronavirus Outbreak and the Treatment Strategies Advanced pharmaceutical bulletin 12(1):34-44 2022 [PMID: 35517888]
  302. Ferrara F, Vitiello A. Renin Angiotensin System and COVID-19 Infection Advanced pharmaceutical bulletin 12(1):1-4 2022 [PMID: 35517880]
  303. Ebrahimi S, Khanbabaei H, Abbasi S, Fani M, Soltani S, Zandi M, Najafimemar Z. CRISPR-Cas System: A Promising Diagnostic Tool for Covid-19 Avicenna journal of medical biotechnology 14(1):3-9 2022 [PMID: 35509363]
  304. Shamabadi A, Akhondzadeh S. Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine Avicenna journal of medical biotechnology 14(1):1-2 2022 [PMID: 35509361]
  305. Rezaei M, Nazari M. New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA Avicenna journal of medical biotechnology 14(1):30-36 2022 [PMID: 35509358]
  306. Sookaromdee P, Wiwanitkit V. Correspondence on COVID-19 Vaccination and Acquired Haemophila A Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 28:10760296221100808 2022 [PMID: 35535392]
  307. Kamath C, Brenner EJ. The safe use of inflammatory bowel disease therapies during the COVID-19 pandemic Current research in pharmacology and drug discovery 3:100101 2022 [PMID: 35496814]
  308. Park JG, Pino PA, Akhter A, Alvarez X, Torrelles JB, Martinez-Sobrido L. Animal Models of COVID-19: Transgenic Mouse Model Methods in molecular biology (Clifton, N.J.) 2452:259-289 2022 [PMID: 35554912]
  309. Hagihara M, Sugi T, Uchida T, Ohara S, Imai Y, Inoue M, Mitamura K. [SARS-CoV2 anti-spike IgG response following COVID-19 mRNA vaccination (BNT162b2) in patients with hematological disorders] [Rinsho ketsueki] The Japanese journal of clinical hematology 63(4):247-253 2022 [PMID: 35491212]
  310. Hossain MJ, Rahman SMA, Emran TB, Mitra S, Islam MR, Dhama K. Recommendation and Roadmap of Mass Vaccination against Coronavirus Disease 2019 Pandemic in Bangladesh as a Lower-Middle-Income Country Archives of Razi Institute 76(6):1823-1830 2021 [PMID: 35546989]
  311. Ritter A, Helmchen B, Gaspert A, Bleisch J, Fritschi B, Buchkremer F, Damm S, Schmid N, Schachtner T, Seeger H. Clinical spectrum of gross haematuria following SARS-CoV-2 vaccination with mRNA vaccines Clinical kidney journal 15(5):961-973 2022 [PMID: 35498904]
  312. Manci R, Jennings T, Mclarney RM, Heymann WR, Sommer LL. An acute, ulcerative, sarcoidal tattoo reaction following SARS-CoV-2 mRNA-1273 vaccination Dermatology online journal 27(12) 2021 [PMID: 35499440]
  313. Hossain MU, Ahammad I, Bhattacharjee A, Chowdhury ZM, Hossain Emon MT, Chandra Das K, Keya CA, Salimullah M. Whole genome sequencing for revealing the point mutations of SARS-CoV-2 genome in Bangladeshi isolates and their structural effects on viral proteins RSC advances 11(61):38868-38879 2021 [PMID: 35493250]
  314. Díaz R F, Ampuero A C, Donoso F A. [Pericarditis after administration mRNA COVID-19 vaccine] Andes pediatrica : revista Chilena de pediatria 92(6):973-975 2021 [PMID: 35506812]
  315. Sharma PP, Bansal M, Sethi A, Poonam, Pena L, Goel VK, Grishina M, Chaturvedi S, Kumar D, Rathi B. Computational methods directed towards drug repurposing for COVID-19: advantages and limitations RSC advances 11(57):36181-36198 2021 [PMID: 35492747]
  316. El-Demerdash A, Al-Karmalawy AA, Abdel-Aziz TM, Elhady SS, Darwish KM, Hassan AHE. Investigating the structure-activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors RSC advances 11(50):31339-31363 2021 [PMID: 35496831]
  317. Munywoki PK, Nasimiyu C, Alando MD, Otieno N, Ombok C, Njoroge R, Kikwai G, Odhiambo D, Osita MP, Ouma A, Odour C, Juma B, Ochieng CA, Mutisya I, Ngere I, Dawa J, Osoro E, Njenga MK, Bigogo G, Munyua P, Lo TQ, Hunsperger E, Herman-Roloff A. Seroprevalence and risk factors of SARS-CoV-2 infection in an urban informal settlement in Nairobi, Kenya, December 2020 F1000Research 10:853 2021 [PMID: 35528961]

Coxiella burnetii (Q fever)

  1. Garg P, Chan S, Peeceeyen S, Youssef G, Graves SR, Sullivan R. Culture-negative polymicrobial chronic Q fever prosthetic valve infective endocarditis utilising 16s rRNA PCR on explanted valvular tissue International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 [PMID: 35562042]

Eastern equine encephalitis virus

  1. Coates EE, Edupuganti S, Chen GL, Happe M, Strom L, Widge A, Florez MB, Cox JH, Gordon I, Plummer S, Ola A, Yamshchikov G, Andrews C, Curate-Ingram S, Morgan P, Nagar S, Collins MH, Bray A, Nguyen T, Stein J, Case CL, Kaltovich F, Wycuff D, Liang CJ, Carlton K, Vazquez S, Mascola JR, Ledgerwood JE. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial The Lancet. Infectious diseases 2022 [PMID: 35568049]

Ebola virus

  1. Alizadeh M, Amini-Khoei H, Tahmasebian S, Ghatrehsamani M, Ghatreh Samani K, Edalatpanah Y, Rostampur S, Salehi M, Ghasemi-Dehnoo M, Azadegan-Dehkordi F, Sanami S, Bagheri N. Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach Scientific reports 12(1):7757 2022 [PMID: 35545650]
  2. Baby B, R R, Nair MM, P R R. Sagacious perceptive on Marburg virus foregrounding the recent findings :A Critical Review Infectious disorders drug targets 2022 [PMID: 35538802]
  3. Drew C, Badio M, Dennis D, Hensley L, Higgs E, Sneller M, Fallah M, Reilly C. Simplifying the estimation of diagnostic testing accuracy over time for high specificity tests in the absence of a gold standard Biometrics 2022 [PMID: 35531799]
  4. Zola Matuvanga T, Larivière Y, Lemey G, De Bie J, Milolo S, Meta R, Esanga E, Vermeiren PP, Thys S, Van Geertruyden JP, Van Damme P, Maketa V, Matangila J, Mitashi P, Muhindo-Mavoko H. Setting-up an Ebola vaccine trial in a remote area of the Democratic Republic of the Congo: Challenges, mitigations, and lessons learned Vaccine 2022 [PMID: 35550847]
  5. Mellors J, Tipton T, Fehling SK, Akoi Bore J, Koundouno FR, Hall Y, Hudson J, Alexander F, Longet S, Taylor S, Gorringe A, Magassouba N, Konde MK, Hiscox J, Strecker T, Carroll M. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis Frontiers in immunology 13:857481 2022 [PMID: 35493467]
  6. Vianello E, Gonzalez-Dias P, van Veen S, Engele CG, Quinten E, Monath TP, Medaglini D, Santoro F, Huttner A, Dubey S, Eichberg M, Ndungu FM, Kremsner PG, Essone PN, Agnandji ST, Siegrist CA, Nakaya HI, Ottenhoff THM, Haks MC. Transcriptomic signatures induced by the Ebola virus vaccine rVSVΔG-ZEBOV-GP in adult cohorts in Europe, Africa, and North America: a molecular biomarker study The Lancet. Microbe 3(2):e113-e123 2022 [PMID: 35544042]

Escherichia coli

  1. Frick-Cheng AE, Sintsova A, Smith SN, Pirani A, Snitkin ES, Mobley HLT. Ferric Citrate Uptake Is a Virulence Factor in Uropathogenic Escherichia coli mBio :e0103522 2022 [PMID: 35546538]
  2. Wilkie M, Tanner R, Wright D, Lopez Ramon R, Beglov J, Riste M, Marshall JL, Harris SA, Bettencourt PJG, Hamidi A, van Diemen PM, Moss P, Satti I, Wyllie D, McShane H. Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study Scientific reports 12(1):7808 2022 [PMID: 35552463]
  3. Alizadeh M, Amini-Khoei H, Tahmasebian S, Ghatrehsamani M, Ghatreh Samani K, Edalatpanah Y, Rostampur S, Salehi M, Ghasemi-Dehnoo M, Azadegan-Dehkordi F, Sanami S, Bagheri N. Designing a novel multi‑epitope vaccine against Ebola virus using reverse vaccinology approach Scientific reports 12(1):7757 2022 [PMID: 35545650]
  4. Feng W, Xiang Y, Wu L, Chen Z, Li Q, Chen J, Guo Y, Xia D, Chen N, Zhang L, Zhu S, Zhao KN. Nucleocapsid protein of SARS-CoV-2 is a potential target for developing new generation of vaccine Journal of clinical laboratory analysis :e24479 2022 [PMID: 35527696]
  5. Ke Q, Sun P, Wang T, Mi T, Xu H, Wu J, Liu B. Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice Journal of immunological methods 506:113279 2022 [PMID: 35533747]
  6. Crothers JW, Ross Colgate E, Cowan KJ, Dickson DM, Walsh M, Carmolli M, Wright PF, Norton EB, Kirkpatrick BD. Corrigendum to "Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized active-controlled trial" [Vaccine 40(19) (2022) 2705-2713] Vaccine 2022 [PMID: 35534312]
  7. Jin S, Wang T, Zhao Y, Liu X, Wang Y, Jiang L, Zhang Q. The heat-labile toxin B subunit of E. coli fused with VP6 from GCRV (Grass carp reovirus) was expressed and folded into an active protein in rice calli Protein expression and purification 197:106099 2022 [PMID: 35525405]
  8. Yue Y, Xu J, Li Y, Cheng K, Feng Q, Ma X, Ma N, Zhang T, Wang X, Zhao X, Nie G. Antigen-bearing outer membrane vesicles as tumour vaccines produced in situ by ingested genetically engineered bacteria Nature biomedical engineering 2022 [PMID: 35501399]
  9. Calderon K, Mitchell JC. Mutagenesis and Enzyme Inhibition Studies of West Nile virus NS2B/NS3 Serine Protease FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35552605]
  10. Asmani F, Khavari-Nejad RA, Salmanian AH, Amani J. Immunological evaluation of recombinant chimeric construct from Enterotoxigenic E. coli expressed in hairy roots Molecular immunology 147:81-89 2022 [PMID: 35504061]
  11. Bemani P, Jalili S, Hassanpour K, Faraji F, Gholijani N, Barazesh M, Mohammadi M, Farnoosh G. Designing and Characterization of Tregitope-Based Multi-Epitope Vaccine Against Multiple Sclerosis: An Immunoinformatic Approach Current drug safety 2022 [PMID: 35507799]
  12. Liu L, Chen T, Zhou L, Sun J, Li Y, Nie M, Xiong H, Zhu Y, Xue W, Wu Y, Li T, Zhang T, Kong Z, Yu H, Zhang J, Gu Y, Zheng Q, Zhao Q, Xia N, Li S. A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice Frontiers in microbiology 13:854630 2022 [PMID: 35558112]
  13. Karyagina AS, Gromov AV, Grunina TM, Lyaschuk AM, Poponova MS, Kleymenov DA, Strukova NV, Generalova MS, Ryazanova AV, Galushkina ZM, Dobrynina OY, Bolshakova TN, Sergeeva MV, Romanovskaya-Romanko EA, Krasilnikov IV, Subbotina ME, Lunin VG. Hybrid Proteins with Short Conformational Epitopes of the Receptor-Binding Domain of SARS-CoV-2 Spike Protein Promote Production of Virus-Neutralizing Antibodies When Used for Immunization Biochemistry. Biokhimiia 87(4):319-330 2022 [PMID: 35527370]
  14. Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H. Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial The Lancet. Microbe 2(9):e429-e440 2021 [PMID: 35544149]

Francisella tularensis (Tularemia)

  1. Kaya E, Üçer H. Tularemia research activity: a bibliometric analysis between 1980 and 2020 Infection 2022 [PMID: 35507235]

Hantavirus

  1. Wen X, Zhang L, Liu Q, Xiao X, Huang W, Wang Y. Screening and Identification of HTNV<sub>pv</sub> Entry Inhibitors with High-throughput Pseudovirus-based Chemiluminescence Virologica Sinica 2022 [PMID: 35513270]
  2. Gutiérrez Jara JP, Muñoz Quezada MT. Modeling of hantavirus cardiopulmonary syndrome Medwave 22(3):e8722 2022 [PMID: 35507807]

Human immunodeficiency virus (acquired immunodeficiency syndrome)

  1. Adibzadeh S, Amiri S, Nia GE, Taleghani MR, Bijarpas ZK, Maserat N, Maali A, Azad M, Behzad-Behbahani A. Therapeutic approaches and vaccination in fighting COVID-19 infections: A review Gene reports 27:101619 2022 [PMID: 35530725]
  2. Nabi-Afjadi M, Heydari M, Zalpoor H, Arman I, Sadoughi A, Sahami P, Aghazadeh S. Lectins and lectibodies: potential promising antiviral agents Cellular & molecular biology letters 27(1):37 2022 [PMID: 35562647]
  3. Boulouis C, Kammann T, Cuapio A, Parrot T, Gao Y, Mouchtaridi E, Wullimann D, Lange J, Chen P, Akber M, Rivera Ballesteros O, Muvva JR, Smith CIE, Vesterbacka J, Kieri O, Nowak P, Bergman P, Buggert M, Ljunggren HG, Aleman S, Sandberg JK. MAIT cell compartment characteristics are associated with the immune response magnitude to the BNT162b2 mRNA anti-SARS-CoV-2 vaccine Molecular medicine (Cambridge, Mass.) 28(1):54 2022 [PMID: 35562666]
  4. Rodríguez-Galet A, Rubio-Garrido M, Valadés-Alcaraz A, Rodríguez-Domínguez M, Galán JC, Ndarabu A, Reina G, Holguín A. Immune surveillance for six vaccinable pathogens using paired plasma and dried blood spots in HIV infected and uninfected children in Kinshasa Scientific reports 12(1):7920 2022 [PMID: 35562589]
  5. Chen D, Bryden NA, Bryden WA, McLoughlin M, Smith D, Devin AP, Caton ER, Haddaway CR, Tameris M, Scriba TJ, Hatherill M, Gessner S, Warner DF, Wood R. Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis Scientific reports 12(1):7919 2022 [PMID: 35562381]
  6. Diamond TL, Ngo W, Xu M, Goh SL, Rodriguez S, Lai MT, Asante-Appiah E, Grobler JA. Islatravir Has a High Barrier to Resistance and Exhibits a Differentiated Resistance Profile from Approved Nucleoside Reverse Transcriptase Inhibitors (NRTIs) Antimicrobial agents and chemotherapy :e0013322 2022 [PMID: 35546110]
  7. Esmael A, Abebe T, Mihret A, Mussa D, Neway S, Ernst J, Rengarajan J, Wassie L, Howe R. Mycobacterium tuberculosis antigen-specific T cell responses in smear- negative pulmonary tuberculosis patients Clinical and experimental immunology 2022 [PMID: 35552657]
  8. Balle C, Armistead B, Kiravu A, Song X, Happel AU, Hoffmann AA, Kanaan SB, Nelson JL, Gray CM, Jaspan HB, Harrington WE. Factors influencing maternal microchimerism throughout infancy and its impact on infant T cell immunity The Journal of clinical investigation 2022 [PMID: 35550376]
  9. Julg B, Stephenson KE, Wagh K, Tan SC, Zash R, Walsh S, Ansel J, Kanjilal D, Nkolola J, Walker-Sperling VEK, Ophel J, Yanosick K, Borducchi EN, Maxfield L, Abbink P, Peter L, Yates NL, Wesley MS, Hassell T, Gelderblom HC, deCamp A, Mayer BT, Sato A, Gerber MW, Giorgi EE, Gama L, Koup RA, Mascola JR, Monczor A, Lupo S, Rolle CP, Arduino R, DeJesus E, Tomaras GD, Seaman MS, Korber B, Barouch DH. Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial Nature medicine 2022 [PMID: 35551291]
  10. Mwimanzi F, Lapointe HR, Cheung PK, Sang Y, Yaseen F, Umviligihozo G, Kalikawe R, Datwani S, Omondi FH, Burns L, Young L, Leung V, Agafitei O, Ennis S, Dong W, Basra S, Lim LY, Ng K, Pantophlet R, Brumme CJ, Montaner JSG, Prystajecky N, Lowe CF, DeMarco ML, Holmes DT, Simons J, Niikura M, Romney MG, Brumme ZL, Brockman MA. Older adults mount less durable humoral responses to two doses of COVID-19 mRNA vaccine, but strong initial responses to a third dose The Journal of infectious diseases 2022 [PMID: 35543278]
  11. Sun J, Zhao G, Bylund T, Lee M, Adibhatla S, Kwong PD, Chuang GY, Rawi R, Bewley CA. <i>C</i><sub>3</sub>-Symmetric Aromatic Core of Griffithsin Is Essential for Potent Anti-HIV Activity ACS chemical biology 2022 [PMID: 35537058]
  12. Tu JJ, Kumar A, Giorgi EE, Eudailey J, LaBranche CC, Martinez DR, Fouda GG, Moreau Y, Thomas A, Montefiori D, Gao F, Sagar M, Permar SR. Vertical HIV-1 Transmission in the Setting of Maternal Broad and Potent Antibody Responses Journal of virology :e0023122 2022 [PMID: 35536018]
  13. Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, Haniffa R, Reveiz L, Ford N, Doherty M, Diaz J. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 The lancet. HIV 2022 [PMID: 35561704]
  14. Park Y, Kim AR, Hwang YH, Yang H, Lee JW, Kim MY, Kim HS, Chung GT, Yoo JS, Kim YJ, Kim D, Won H. Comparison of Plaque Reduction and Focus Reduction Neutralization Tests for the Measurement of Neutralizing Antibody Titers Against Japanese Encephalitis Virus Journal of virological methods :114540 2022 [PMID: 35550887]
  15. Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG. The clinical progress of mRNA vaccines and immunotherapies Nature biotechnology 2022 [PMID: 35534554]
  16. Nyitray AG, Masunaga KIA, Nyoni J, Ross MW. Prevalence of and factors associated with anal high-risk human papillomavirus in urban Tanzanian men who have sex with men, 2011-2012 International journal of STD & AIDS :9564624221094456 2022 [PMID: 35531601]
  17. Warr AJ, Anterasian C, Shah JA, De Rosa SC, Nguyen FK, Maleche-Obimbo E, Cranmer LM, Matemo D, Mecha J, Kinuthia J, LaCourse SM, John-Stewart GC, Hawn TR. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV EBioMedicine 80:104023 2022 [PMID: 35533496]
  18. Breitschwerdt S, Schwarze-Zander C, Al Tayy A, Mutevelli J, Wasmuth JC, Rockstroh JK, Boesecke C. Implementation of EACS vaccination recommendations among people living with HIV Infection 2022 [PMID: 35522383]
  19. Gray MD, Feng J, Weidle CE, Cohen KW, Ballweber-Fleming L, MacCamy AJ, Huynh CN, Trichka JJ, Montefiori D, Ferrari G, Pancera M, McElrath MJ, Stamatatos L. Characterization of a vaccine-elicited human antibody with sequence homology to VRC01-class antibodies that binds the C1C2 gp120 domain Science advances 8(18):eabm3948 2022 [PMID: 35507661]
  20. Cho M, Min X, Son HS. Analysis of evolutionary and genetic patterns in structural genes of primate lentiviruses Genes & genomics 2022 [PMID: 35511321]
  21. Sacks D, Wiehe K, Morris L, Moore PL. Complementary Roles of Antibody Heavy and Light Chain Somatic Hypermutation in Conferring Breadth and Potency to the HIV-1-Specific CAP256-VRC26 bNAb Lineage Journal of virology :e0027022 2022 [PMID: 35510865]
  22. Nault L, Marchitto L, Goyette G, Tremblay-Sher D, Fortin C, Martel-Laferrière V, Trottier B, Richard J, Durand M, Kaufmann D, Finzi A, Tremblay C. Covid-19 vaccine immunogenicity in people living with HIV-1 Vaccine 2022 [PMID: 35568588]
  23. Gray G, Collie S, Goga A, Garrett N, Champion J, Seocharan I, Bamford L, Moultrie H, Bekker LG. Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa The New England journal of medicine 2022 [PMID: 35507482]
  24. Taylor MM, Wi T, Gerbase A, Thwin SS, Gottlieb S, Babovic MT, Low-Beer D, Alonso M, Mello MB, Ishikawa N, Brink A, Hermez J, Sabry A, Sanni S, Ouedraogo L, Rewari B, Sharma M, Seguy N, Vovc E, Askew I, Doherty M, Broutet N. Assessment of country implementation of the WHO global health sector strategy on sexually transmitted infections (2016-2021) PloS one 17(5):e0263550 2022 [PMID: 35507535]
  25. Meng Y, Zhong J, Lv Y, Zou W. Research progress on HIV-1 immune escape mechanisms AIDS reviews 2022 [PMID: 35504029]
  26. Doan TA, Forward T, Tamburini BAJ. Trafficking and retention of protein antigens across systems and immune cell types Cellular and molecular life sciences : CMLS 79(5):275 2022 [PMID: 35505125]
  27. Dong L, Bogart LM, Gandhi P, Aboagye JB, Ryan S, Serwanga R, Ojikutu BO. A qualitative study of COVID-19 vaccine intentions and mistrust in Black Americans: Recommendations for vaccine dissemination and uptake PloS one 17(5):e0268020 2022 [PMID: 35503797]
  28. Bender Ignacio RA, Long J, Saha A, Nguyen FK, Joudeh L, Valinetz E, Mendelsohn SC, Scriba TJ, Hatherill M, Janes H, Churchyard G, Buchbinder S, Duerr A, Shah JA, Hawn TR. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition PloS one 17(5):e0267729 2022 [PMID: 35503767]
  29. Welbourn S, Chakraborty S, Yang JE, Gleinich AS, Gangadhara S, Khan S, Ferrebee C, Yagnik B, Burton S, Charles T, Smith SA, Williams D, Mopuri R, Upadhyay AA, Thompson J, Price MA, Wang S, Qin Z, Shen X, Williams LD, Eisel N, Peters T, Zhang L, Kilembe W, Karita E, Tomaras GD, Bosinger SE, Amara RR, Azadi P, Wright ER, Gnanakaran S, Derdeyn CA. A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence PLoS pathogens 18(5):e1010488 2022 [PMID: 35503780]
  30. Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects Signal transduction and targeted therapy 7(1):146 2022 [PMID: 35504917]
  31. Lai MT, Feng M, Xu M, Ngo W, Diamond TL, Hwang C, Grobler JA, Hazuda DJ, Asante-Appiah E. Doravirine and Islatravir Have Complementary Resistance Profiles and Create a Combination with a High Barrier to Resistance Antimicrobial agents and chemotherapy :e0222321 2022 [PMID: 35491829]
  32. Rudometova NB, Shcherbakova NS, Shcherbakov DN, Taranov OS, Zaitsev BN, Karpenko LI. Construction and Characterization of HIV-1 env-Pseudoviruses of the Recombinant Form CRF63_02A and Subtype A6 Bulletin of experimental biology and medicine 2022 [PMID: 35501651]
  33. Tariq M, Gallien S, Surenaud M, Wiedemann A, Jean-Louis F, Lacabaratz C, Lopez Zaragoza JL, Zeitoun JD, Ysmail-Dalhouk S, Lelièvre JD, Lévy Y, Hüe S. Profound Defect of Amphiregulin Secretion by Regulatory T Cells in the Gut of HIV-Treated Patients Journal of immunology (Baltimore, Md. : 1950) 2022 [PMID: 35500933]
  34. Nantanee R, Aikphaibul P, Jaru-Ampornpan P, Sodsai P, Himananto O, Theerawit T, Sophonphan J, Tovichayathamrong P, Manothummetha K, Laohasereekul T, Hiransuthikul N, Hirankarn N, Puthanakit T. Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac Vaccine 2022 [PMID: 35513961]
  35. Wen X, Zhang L, Liu Q, Xiao X, Huang W, Wang Y. Screening and Identification of HTNV<sub>pv</sub> Entry Inhibitors with High-throughput Pseudovirus-based Chemiluminescence Virologica Sinica 2022 [PMID: 35513270]
  36. Hicks EG, Kandel SE, Lampe JN. Identification of Aloe-derived natural products as lead scaffolds for SARS-CoV-2 main protease (M<sup>pro</sup> ) inhibitors FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35560891]
  37. Finkelstein MT, Erdman MC, Fera D. Characterization of the DH475 cooperating antibody and its interaction with the HIV-1 spike FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555889]
  38. Anguiano A, Kulesza C. Human Cytomegalovirus (HCMV) Tegument Protein pUL35 in the establishment of latency in models of quiescent infection FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555400]
  39. Canziani GA, Tang J, Nangarlia A, Zhang S, Fazloon-Hassen F, Taludker C, Connors J, Cusimano G, Bernui M, Bell M, Kutzler M, Haddad E, Cairns C, Chaiken I. Anti-S2 Protection in COVID-19 Infection and SARS-CoV-2 Spike Vaccination FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35554532]
  40. Nazim T. Cellular localization, immunological function and biophysical characterization of Mycobacterium tuberculosis Methyltransferases FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35552769]
  41. Parker Miller E, Fera D. Analysis of the interactions between the HIV-1 Spike and the F7-22 "cooperating" antibody FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35552282]
  42. Mayanja Y, Kamacooko O, Lunkuse JF, Muturi-Kioi V, Buzibye A, Omali D, Chinyenze K, Kuteesa M, Kaleebu P, Price MA. Oral pre-exposure prophylaxis preference, uptake, adherence and continuation among adolescent girls and young women in Kampala, Uganda: a prospective cohort study Journal of the International AIDS Society 25(5):e25909 2022 [PMID: 35543110]
  43. Madhi SA, Moodley D, Hanley S, Archary M, Hoosain Z, Lalloo U, Louw C, Fairlie L, Fouche LF, Masilela MSL, Singh N, Grobbelaar C, Ahmed K, Benadé G, Bhikha S, Bhorat AE, Bhorat Q, Joseph N, Dheda K, Esmail A, Foulkes S, Goga A, Oommen Jose A, Kruger G, Kalonji DJ, Lalloo N, Lombaard JJ, Lombard Koen A, Kany Luabeya A, Mngqibisa R, Petrick FG, Pitsi A, Tameris M, Thombrayil A, Vollgraaff PL, Cloney-Clark S, Zhu M, Bennett C, Albert G, Faust E, Plested JS, Fries L, Robertson A, Neal S, Cho I, Glenn GM, Shinde V. Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial The lancet. HIV 9(5):e309-e322 2022 [PMID: 35489376]
  44. Deimel LP, Sattentau QJ. Shared sugars - parasite glycan homology in HIV-1 vaccine design Trends in parasitology 2022 [PMID: 35501266]
  45. Ousseine YM, Vaux S, Vandentorren S, Bonmarin I, Champenois K, Lydié N, Velter A. Predictors of Uncertainty and Unwillingness to Receive the COVID-19 Vaccine in Men Who Have Sex with Men in France International journal of environmental research and public health 19(9) 2022 [PMID: 35564769]
  46. Yoshimura Y, Sasaki H, Miyata N, Tachikawa N. Intradermal Hepatitis B Vaccination in Non-Responder People Living with HIV in Japan Japanese journal of infectious diseases 2022 [PMID: 35491226]
  47. Maimongkol P, Yonwises W, Anugulruengkitt S, Sophonphan J, Treyaprasert W, Wacharachaisurapol N. Therapeutic drug monitoring of meropenem and pharmacokinetic-pharmacodynamic target assessment in critically ill pediatric patients from a prospective observational study International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 120:96-9102 2022 [PMID: 35489632]
  48. Huang HY, Chan PC, Huang YC, Lo HY, Lee PH, Yang CH, Kuo HW, Lee CC. An outbreak of SARS-CoV-2 infections among people living with HIV and its successful containment-Taiwan, May to August 2021 Journal of the Formosan Medical Association = Taiwan yi zhi 2022 [PMID: 35568663]
  49. Tumba NL, Naicker P, Stoychev S, Killick MA, Owen GR, Papathanasopoulos MA. Covalent binding of human two-domain CD4 to an HIV-1 subtype C SOSIP.664 trimer modulates its structural dynamics Biochemical and biophysical research communications 612:181-187 2022 [PMID: 35550505]
  50. Nakhaeizadeh M, Chegeni M, Adhami M, Sharifi H, Gohari MA, Iranpour A, Azizian M, Mashinchi M, Baneshi MR, Karamouzian M, Haghdoost AA, Jahani Y. Estimating the Number of COVID-19 Cases and Impact of New COVID-19 Variants and Vaccination on the Population in Kerman, Iran: A Mathematical Modeling Study Computational and mathematical methods in medicine 2022:6624471 2022 [PMID: 35495892]
  51. Mulenga H, Fiore-Gartland A, Mendelsohn SC, Penn-Nicholson A, Mbandi SK, Nemes E, Borate B, Musvosvi M, Tameris M, Walzl G, Naidoo K, Churchyard G, Scriba TJ, Hatherill M. Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study EClinicalMedicine 47:101396 2022 [PMID: 35497063]
  52. Nziza N, Cizmeci D, Davies L, Irvine EB, Jung W, Fenderson BA, de Kock M, Hanekom WA, Franken KLMC, Day CL, Ottenhoff THM, Alter G. Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis Frontiers in immunology 13:856906 2022 [PMID: 35514994]
  53. Motsoeneng BM, Dhar N, Nunes MC, Krammer F, Madhi SA, Moore PL, Richardson SI. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV Frontiers in immunology 13:873191 2022 [PMID: 35514992]
  54. Troyano-Hernáez P, Reinosa R, Holguín Á. HIV Capsid Protein Genetic Diversity Across HIV-1 Variants and Impact on New Capsid-Inhibitor Lenacapavir Frontiers in microbiology 13:854974 2022 [PMID: 35495642]
  55. Odera S, Mureithi M, Aballa A, Onyango N, Kazungu S, Ogolla S, Kaiyare G, Anzala O, Oyugi J. Association between human leukocyte antigen class II (HLA-DRB and -DQB) alleles and outcome of exposure to <i>Mycobacterium tuberculosis</i>: a cross-sectional study in Nairobi, Kenya The Pan African medical journal 41:149 2022 [PMID: 35519172]
  56. Akanda R, Kawale P, Moucheraud C. Cervical cancer prevention in Africa: A policy analysis Journal of cancer policy 32:100321 2022 [PMID: 35560260]
  57. Neerukonda SN, Vassell R, Weiss CD, Wang W. Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses Methods in molecular biology (Clifton, N.J.) 2452:305-314 2022 [PMID: 35554914]
  58. Unemo M, Lahra MM, Escher M, Eremin S, Cole MJ, Galarza P, Ndowa F, Martin I, Dillon JR, Galas M, Ramon-Pardo P, Weinstock H, Wi T. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study The Lancet. Microbe 2(11):e627-e636 2021 [PMID: 35544082]

Marburg virus

  1. Baby B, R R, Nair MM, P R R. Sagacious perceptive on Marburg virus foregrounding the recent findings :A Critical Review Infectious disorders drug targets 2022 [PMID: 35538802]
  2. Shaban MS, Mayr-Buro C, Meier-Soelch J, Albert BV, Schmitz ML, Ziebuhr J, Kracht M. Thapsigargin: key to new host-directed coronavirus antivirals? Trends in pharmacological sciences 2022 [PMID: 35534355]
  3. Mellors J, Tipton T, Fehling SK, Akoi Bore J, Koundouno FR, Hall Y, Hudson J, Alexander F, Longet S, Taylor S, Gorringe A, Magassouba N, Konde MK, Hiscox J, Strecker T, Carroll M. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis Frontiers in immunology 13:857481 2022 [PMID: 35493467]

Mycobacterium tuberculosis (tuberculosis)

  1. Lee JM, Park J, Reed SG, Coler RN, Hong JJ, Kim LH, Lee W, Kwon KW, Shin SJ. Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against <i>Mycobacterium avium</i> infection but is ineffective as an adjunct to antibiotic treatment in chronic disease Virulence 13(1):808-832 2022 [PMID: 35499090]
  2. Chen D, Bryden NA, Bryden WA, McLoughlin M, Smith D, Devin AP, Caton ER, Haddaway CR, Tameris M, Scriba TJ, Hatherill M, Gessner S, Warner DF, Wood R. Non-volatile organic compounds in exhaled breath particles correspond to active tuberculosis Scientific reports 12(1):7919 2022 [PMID: 35562381]
  3. Esmael A, Abebe T, Mihret A, Mussa D, Neway S, Ernst J, Rengarajan J, Wassie L, Howe R. Mycobacterium tuberculosis antigen-specific T cell responses in smear- negative pulmonary tuberculosis patients Clinical and experimental immunology 2022 [PMID: 35552657]
  4. Moodley A, Fatoba A, Okpeku M, Emmanuel Chiliza T, Blessing Cedric Simelane M, Pooe OJ. Reverse vaccinology approach to design a multi-epitope vaccine construct based on the Mycobacterium tuberculosis biomarker PE_PGRS17 Immunologic research 2022 [PMID: 35554858]
  5. Richards B, Rao K, Bishai D. District-level religious composition and child health in India Journal of health, population, and nutrition 41(1):19 2022 [PMID: 35550656]
  6. Wilkie M, Tanner R, Wright D, Lopez Ramon R, Beglov J, Riste M, Marshall JL, Harris SA, Bettencourt PJG, Hamidi A, van Diemen PM, Moss P, Satti I, Wyllie D, McShane H. Functional in-vitro evaluation of the non-specific effects of BCG vaccination in a randomised controlled clinical study Scientific reports 12(1):7808 2022 [PMID: 35552463]
  7. Li HR, Yao C, Li SS, Wang W, Pang Y. [Progress of regulatory T cells in the regulation of anti-tuberculosis immunity] Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases 45(5):502-509 2022 [PMID: 35527466]
  8. Saleki K, Alijanizade P, Moradi S, Rahmani A, Banazadeh M, Mohamadi MH, Shahabi F, Nouri HR. Engineering a novel immunogenic chimera protein utilizing bacterial infections associated with atherosclerosis to induce a deviation in adaptive immune responses via Immunoinformatics approaches Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases :105290 2022 [PMID: 35568333]
  9. Bertagnolio S, Thwin SS, Silva R, Nagarajan S, Jassat W, Fowler R, Haniffa R, Reveiz L, Ford N, Doherty M, Diaz J. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 The lancet. HIV 2022 [PMID: 35561704]
  10. Warr AJ, Anterasian C, Shah JA, De Rosa SC, Nguyen FK, Maleche-Obimbo E, Cranmer LM, Matemo D, Mecha J, Kinuthia J, LaCourse SM, John-Stewart GC, Hawn TR. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV EBioMedicine 80:104023 2022 [PMID: 35533496]
  11. Ding Y, Wang L, Li H, Miao F, Zhang Z, Hu C, Yu W, Tang Q, Shao G. Application of lipid nanovesicle drug delivery system in cancer immunotherapy Journal of nanobiotechnology 20(1):214 2022 [PMID: 35524277]
  12. Chong KC, Yeoh EK, Leung CC, Lau SYF, Lam HCY, Goggins WB, Zhao S, Ran J, Mohammad KN, Chan RWY, Lai CKC, Chan PKS, Leung CSY, Chen VXY, Wang Y, Wei Y. Independent effect of weather, air pollutants, and seasonal influenza on risk of tuberculosis hospitalization: An analysis of 22-year hospital admission data The Science of the total environment 837:155711 2022 [PMID: 35523336]
  13. Diray-Arce J, Angelidou A, Jensen KJ, Conti MG, Kelly RS, Pettengill MA, Liu M, van Haren SD, McCulloch SD, Michelloti G, Idoko O, Kollmann TR, Kampmann B, Steen H, Ozonoff A, Lasky-Su J, Benn CS, Levy O. Bacille Calmette-Guérin vaccine reprograms human neonatal lipid metabolism in vivo and in vitro Cell reports 39(5):110772 2022 [PMID: 35508141]
  14. Bender Ignacio RA, Long J, Saha A, Nguyen FK, Joudeh L, Valinetz E, Mendelsohn SC, Scriba TJ, Hatherill M, Janes H, Churchyard G, Buchbinder S, Duerr A, Shah JA, Hawn TR. Mycobacterium tuberculosis infection, immune activation, and risk of HIV acquisition PloS one 17(5):e0267729 2022 [PMID: 35503767]
  15. Vu H, Gilari K, Sathiyamoorthy V, Beckham J. Discovery of Novel Inhibitors for Mycobacterium tuberculosis D-alanine: D-alanine Ligase through Virtual Screening FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35555636]
  16. Robbins L, Najibi Z, Conrad W. Engineering Prophylactic Biosynthesis of an Antituberculosis Antibiotic FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35553520]
  17. Nazim T. Cellular localization, immunological function and biophysical characterization of Mycobacterium tuberculosis Methyltransferases FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35552769]
  18. Capeding TPJ, Rosa JD, Lam H, Gaviola DG, Garfin AMC, Hontiveros C, Cunnama L, Laurence YV, Kitson N, Vassall A, Sweeney S, Garcia-Baena I. Cost of TB prevention and treatment in the Philippines in 2017 The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 26(5):392-398 2022 [PMID: 35505478]
  19. Srioetami Tanoerahardjo F, Rooslamiati I, Kipuw N, Hadiyanto, Ali S, Sahiratmadja E. Interferon gamma release assay post BCG among newborns and family members living in a crowded area in Jakarta, Indonesia Journal of infection in developing countries 16(4):638-643 2022 [PMID: 35544625]
  20. Aborode AT, Fajemisin EA, Aiyenuro EA, Alakitan M, Ariwoola MO, Imisioluwa JO, Rafiu R, Alexiou A. Neglected Tropical Diseases (NTDs) and COVID-19 pandemic in Africa: Special focus on control strategies Combinatorial chemistry & high throughput screening 2022 [PMID: 35490317]
  21. Hassani S, Nadji PS, Mohseni A, Rahnamaye Farzami M, Mirab Samiee S, Sadr M, Nadji SA. Evaluation Frequency of Human Papillomavirus and Its Related Genotypes in Women of the General Population Living in 11 Provinces of Iran The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2022:8668557 2022 [PMID: 35528803]
  22. Nijman RG, Bressan S, Brandenberger J, Kaur D, Keitel K, Maconochie IK, Oostenbrink R, Parri N, Shavit I, Teksam O, Velasco R, van de Voorde P, Da Dalt L, Guchtenaere A, Hadjipanayis AA, Ross Russell R, Del Torso S, Bognar Z, Titomanlio L. Update on the Coordinated Efforts of Looking After the Health Care Needs of Children and Young People Fleeing the Conflict Zone of Ukraine Presenting to European Emergency Departments-A Joint Statement of the European Society for Emergency Paediatrics and the European Academy of Paediatrics Frontiers in pediatrics 10:897803 2022 [PMID: 35558376]
  23. Ábalos P, Valdivieso N, Pérez de Val B, Vordermeier M, Benavides MB, Alegría-Morán R, Saadi K, Wistuba M, Ortega C, Sánchez N, Retamal P. Vaccination of Calves with the <i>Mycobacterium bovis</i> BCG Strain Induces Protection against Bovine Tuberculosis in Dairy Herds under a Natural Transmission Setting Animals : an open access journal from MDPI 12(9) 2022 [PMID: 35565515]
  24. Mulenga H, Fiore-Gartland A, Mendelsohn SC, Penn-Nicholson A, Mbandi SK, Nemes E, Borate B, Musvosvi M, Tameris M, Walzl G, Naidoo K, Churchyard G, Scriba TJ, Hatherill M. Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study EClinicalMedicine 47:101396 2022 [PMID: 35497063]
  25. Nziza N, Cizmeci D, Davies L, Irvine EB, Jung W, Fenderson BA, de Kock M, Hanekom WA, Franken KLMC, Day CL, Ottenhoff THM, Alter G. Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis Frontiers in immunology 13:856906 2022 [PMID: 35514994]
  26. Molina-Olvera G, Rivas-Ortiz CI, Schcolnik-Cabrera A, Castillo-Rodal AI, López-Vidal Y. RNA Microarray-Based Comparison of Innate Immune Phenotypes between Human THP-1 Macrophages Stimulated with Two BCG Strains International journal of molecular sciences 23(9) 2022 [PMID: 35562916]
  27. Subramanian S, Srinivasan S, Ramaiyan Selvaraju K, Vinoli PM, Selladurai S, Ramasamy B, Kumaragurubaran K, Bakker D, Vordermeier M, Kapur V, Gopal DR. Defined Antigen Skin Test for Bovine Tuberculosis Retains Specificity on Revaccination With Bacillus Calmette-Guérin Frontiers in veterinary science 9:814227 2022 [PMID: 35498753]
  28. Lewinsohn DM, Lewinsohn DA. The Missing Link in Correlates of Protective Tuberculosis Immunity: Recognizing the Infected Cell Frontiers in immunology 13:869057 2022 [PMID: 35493495]
  29. Lv W, He P, Ma Y, Tan D, Li F, Xie T, Han J, Wang J, Mi Y, Niu H, Zhu B. Optimizing the Boosting Schedule of Subunit Vaccines Consisting of BCG and "Non-BCG" Antigens to Induce Long-Term Immune Memory Frontiers in immunology 13:862726 2022 [PMID: 35493466]
  30. Sami CA, Hassan SS, Khan AH, Hasan MN, Arafat SM. A Young Female With Borderline Lepromatous Leprosy and Tuberculous Lymphadenitis: A Rare Coinfection Cureus 14(4):e23892 2022 [PMID: 35530889]
  31. Peterson RR, Ramya R, Kuruvilla A, Lakshmi KS. Multiple tuberculomas and cavitating pulmonary tuberculosis in an infant Journal of family medicine and primary care 11(4):1536-1538 2022 [PMID: 35516714]
  32. Ravichandran M, Tew HX, Prabhakaran G, Parasuraman S, Norazmi MN. Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine-A Research and Development Journey: Light at the End of a Long Tunnel The Malaysian journal of medical sciences : MJMS 29(2):1-7 2022 [PMID: 35528817]
  33. Odera S, Mureithi M, Aballa A, Onyango N, Kazungu S, Ogolla S, Kaiyare G, Anzala O, Oyugi J. Association between human leukocyte antigen class II (HLA-DRB and -DQB) alleles and outcome of exposure to <i>Mycobacterium tuberculosis</i>: a cross-sectional study in Nairobi, Kenya The Pan African medical journal 41:149 2022 [PMID: 35519172]
  34. DeLucia DC, Lee JK. Development of Cancer Immunotherapies Cancer treatment and research 183:1-48 2022 [PMID: 35551655]

Plasmodium falciparum (Malaria)

  1. Acosta-Pérez T, Rodríguez-Yánez T, Almanza-Hurtado A, Martínez-Ávila MC, Dueñas-Castell C. Dynamics of dengue and SARS-COV-2 co-infection in an endemic area of Colombia Tropical diseases, travel medicine and vaccines 8(1):12 2022 [PMID: 35568905]
  2. Grant J, Gyan T, Agbokey F, Webster J, Greenwood B, Asante KP. Challenges and lessons learned during the planning and early implementation of the RTS,S/AS01<sub>E</sub> malaria vaccine in three regions of Ghana: a qualitative study Malaria journal 21(1):147 2022 [PMID: 35550113]
  3. Asmare G. Willingness to accept malaria vaccine among caregivers of under-5 children in Southwest Ethiopia: a community based cross-sectional study Malaria journal 21(1):146 2022 [PMID: 35549710]
  4. Nkomba NN, Cairo C, Laufer MK. RTS,S today and tomorrow's science Cell host & microbe 30(5):604-606 2022 [PMID: 35550662]
  5. Nugroho AE, Tange M, Kusakabe S, Hirasawa Y, Shirota O, Matsuno M, Mizukami H, Tougan T, Horii T, Morita H. Chukranoids A-I, isopimarane diterpenoids from Chukrasia velutina Journal of natural medicines 2022 [PMID: 35511335]
  6. Okunlola OA, Oyeyemi OT. Malaria transmission in Africa: Its relationship with yellow fever and measles PloS one 17(5):e0268080 2022 [PMID: 35507574]
  7. Miauton A, De Vallière S, Genton B. [Travel vaccines: what is in the pipeline?] Revue medicale suisse 18(780):890-893 2022 [PMID: 35510280]
  8. Gopinathan U. Vaksinen som kan forebygge malaria Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 142(7) 2022 [PMID: 35510454]
  9. Dobelhoff K, Dobelhoff B, Fraley J, Suder KC, Replogle JB. Investigating the Protective Antibody-Circumsporozoite Complex of Plasmodium falciparum and its Role in Vaccine Development FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35554121]
  10. Kitro A, Ngamprasertchai T, Srithanaviboonchai K. Infectious diseases and predominant travel-related syndromes among long-term expatriates living in low-and middle- income countries: a scoping review Tropical diseases, travel medicine and vaccines 8(1):11 2022 [PMID: 35490249]
  11. Poje G, Pessanha de Carvalho L, Held J, Moita D, Prudêncio M, Perković I, Tandarić T, Vianello R, Rajić Z. Design and synthesis of harmiquins, harmine and chloroquine hybrids as potent antiplasmodial agents European journal of medicinal chemistry 238:114408 2022 [PMID: 35551033]
  12. Perera DJ, Hassan AS, Liu SS, Elahi SM, Gadoury C, Weeratna RD, Gilbert R, Ndao M. A low dose adenovirus vectored vaccine expressing Schistosoma mansoni Cathepsin B protects from intestinal schistosomiasis in mice EBioMedicine 80:104036 2022 [PMID: 35500538]
  13. Aborode AT, Fajemisin EA, Aiyenuro EA, Alakitan M, Ariwoola MO, Imisioluwa JO, Rafiu R, Alexiou A. Neglected Tropical Diseases (NTDs) and COVID-19 pandemic in Africa: Special focus on control strategies Combinatorial chemistry & high throughput screening 2022 [PMID: 35490317]
  14. White M, Chitnis CE. Potential role of vaccines in elimination of Plasmodium vivax Parasitology international :102592 2022 [PMID: 35489701]
  15. Nunes-Cabaço H, Moita D, Rôla C, Mendes AM, Prudêncio M. Impact of Dietary Protein Restriction on the Immunogenicity and Efficacy of Whole-Sporozoite Malaria Vaccination Frontiers in immunology 13:869757 2022 [PMID: 35529859]
  16. Mellors J, Tipton T, Fehling SK, Akoi Bore J, Koundouno FR, Hall Y, Hudson J, Alexander F, Longet S, Taylor S, Gorringe A, Magassouba N, Konde MK, Hiscox J, Strecker T, Carroll M. Complement-Mediated Neutralisation Identified in Ebola Virus Disease Survivor Plasma: Implications for Protection and Pathogenesis Frontiers in immunology 13:857481 2022 [PMID: 35493467]
  17. Hegazy MI, Hegazy AM, Saad AM, Salem HM, El-Tahan AM, El-Saadony MT, Soliman SM, Taha AE, Alshehri MA, Ezzat Ahmed A, Swelum AA. ٍSome biologically active microorganisms have the potential to suppress mosquito larvae (<i>Culex pipiens</i>, Diptera: Culicidae) Saudi journal of biological sciences 29(4):1998-2006 2022 [PMID: 35531139]
  18. Latif ENM, Shahari S, Amir A, Cheong FW, Lau YL, Abdullah ML, Fong MY. Genetic diversity of Duffy binding protein 2 region II ofPlasmodium cynomolgi from wild macaques in Peninsular Malaysia Tropical biomedicine 39(1):66-72 2022 [PMID: 35507927]
  19. Oboh MA, Omoleke S, Salami K. Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa The Pan African medical journal 41:148 2022 [PMID: 35519174]
  20. Rivera-Patron M, Cibulski SP, Miraballes I, Silveira F. Formulation of IMXQB: Nanoparticles Based on Quillaja brasiliensis Saponins to be Used as Vaccine Adjuvants Methods in molecular biology (Clifton, N.J.) 2469:183-191 2022 [PMID: 35508839]
  21. Enders MH, Bayarsaikhan G, Ghilas S, Chua YC, May R, de Menezes MN, Ge Z, Tan PS, Cozijnsen A, Mollard V, Yui K, McFadden GI, Lahoud MH, Caminschi I, Purcell AW, Schittenhelm RB, Beattie L, Heath WR, Fernandez-Ruiz D. <i>Plasmodium berghei</i> Hsp90 contains a natural immunogenic I-A<sup>b</sup>-restricted antigen common to rodent and human <i>Plasmodium</i> species Current research in immunology 2:79-92 2021 [PMID: 35492393]

Salmonella

  1. Senevirathne A, Hewawaduge C, Lee JH. Assessing an O-antigen deficient, live attenuated Salmonella Gallinarium strain that is DIVA compatible, environmentally safe, and protects chickens against fowl typhoid Developmental and comparative immunology :104433 2022 [PMID: 35568244]
  2. Barai L, Hasan MR, Haq JA, Ahsan CR. Salmonellacidal Antibody Response to Salmonella enterica serovar Typhi in Enteric Fever and After Vaccination with Vi Capsular Polysaccharide International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 [PMID: 35568365]
  3. Mkhikian H, Hayama KL, Khachikyan K, Li C, Zhou RW, Pawling J, Klaus S, Tran PQN, Ly KM, Gong AD, Saryan H, Hai JL, Grigoryan D, Lee PL, Newton BL, Raffatellu M, Dennis JW, Demetriou M. Age-associated impairment of T cell immunity is linked to sex-dimorphic elevation of N-glycan branching Nature aging 2(3):231-242 2022 [PMID: 35528547]

Shigella

  1. van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA. The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against <i>Shigella</i> ACS central science 8(4):449-460 2022 [PMID: 35559427]
  2. Yuki Y, Nojima M, Hosono O, Tanaka H, Kimura Y, Satoh T, Imoto S, Uematsu S, Kurokawa S, Kashima K, Mejima M, Nakahashi-Ouchida R, Uchida Y, Marui T, Yoshikawa N, Nagamura F, Fujihashi K, Kiyono H. Oral MucoRice-CTB vaccine for safety and microbiota-dependent immunogenicity in humans: a phase 1 randomised trial The Lancet. Microbe 2(9):e429-e440 2021 [PMID: 35544149]

Variola major (Smallpox)

  1. Bifulco M, Di Zazzo E, Pisanti S, Martini M, Orsini D. The nineteenth-century experience of the kingdom of the two Sicilies on mandatory vaccination: An Italian phenomenon? Vaccine 2022 [PMID: 35534315]
  2. Levine Z, Earn DJD. Face masking and COVID-19: potential effects of variolation on transmission dynamics Journal of the Royal Society, Interface 19(190):20210781 2022 [PMID: 35506215]

Venezuelan equine encephalitis virus

  1. Coates EE, Edupuganti S, Chen GL, Happe M, Strom L, Widge A, Florez MB, Cox JH, Gordon I, Plummer S, Ola A, Yamshchikov G, Andrews C, Curate-Ingram S, Morgan P, Nagar S, Collins MH, Bray A, Nguyen T, Stein J, Case CL, Kaltovich F, Wycuff D, Liang CJ, Carlton K, Vazquez S, Mascola JR, Ledgerwood JE. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial The Lancet. Infectious diseases 2022 [PMID: 35568049]

Vibrio cholerae

  1. Mohamed NS, Ali Y, Abdalrahman S, Ahmed A, Siddig EE. The use of cholera oral vaccine for containment of the 2019 disease outbreak in Sudan Transactions of the Royal Society of Tropical Medicine and Hygiene 2022 [PMID: 35537855]
  2. Rawangkan A, Siriphap A, Yosboonruang A, Kiddee A, Pook-In G, Saokaew S, Sutheinkul O, Duangjai A. Potential Antimicrobial Properties of Coffee Beans and Coffee By-Products Against Drug-Resistant <i>Vibrio cholerae</i> Frontiers in nutrition 9:865684 2022 [PMID: 35548583]
  3. Li Q, Chen S, Yan Z, Fang H, Wang Z, He C. A Novel Intranasal Vaccine With PmpGs + MOMP Induces Robust Protections Both in Respiratory Tract and Genital System Posting <i>Chlamydia psittaci</i> Infection Frontiers in veterinary science 9:855447 2022 [PMID: 35529835]
  4. Ravichandran M, Tew HX, Prabhakaran G, Parasuraman S, Norazmi MN. Live, Genetically Attenuated, Cold-Chain-Free Cholera Vaccine-A Research and Development Journey: Light at the End of a Long Tunnel The Malaysian journal of medical sciences : MJMS 29(2):1-7 2022 [PMID: 35528817]

Western equine encephalitis virus

  1. Coates EE, Edupuganti S, Chen GL, Happe M, Strom L, Widge A, Florez MB, Cox JH, Gordon I, Plummer S, Ola A, Yamshchikov G, Andrews C, Curate-Ingram S, Morgan P, Nagar S, Collins MH, Bray A, Nguyen T, Stein J, Case CL, Kaltovich F, Wycuff D, Liang CJ, Carlton K, Vazquez S, Mascola JR, Ledgerwood JE. Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial The Lancet. Infectious diseases 2022 [PMID: 35568049]

Yersinia pestis (Plague)

  1. Nikitina A, Sergeev D, Kovalev S, Trushkin V. NT-proBNP as a diagnostic marker of dilated cardiomyopathy in dogs FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 Suppl 1 2022 [PMID: 35560662]
  2. Ning Y, Huang Y, Wang M, Cheng A, Jia R, Liu M, Zhu D, Chen S, Zhao X, Zhang S, Yang Q, Wu Y, Huang J, Tian B, Ou X, Mao S, Gao Q, Sun D, Yu Y, Zhang L. Evaluation of the Safety and Immunogenicity of Duck-Plague Virus <i>gE</i> Mutants Frontiers in immunology 13:882796 2022 [PMID: 35515004]

Click HERE to see the publications in the last month.